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1.1. Erythrocyte membrane structure 
 
The main function of human erythrocytes is the transport of oxygen from the lungs to the 
tissues. The efficiency of this function depends on different factors specially the activity 
and the structure of membrane erythrocytes. The erythrocyte membrane contains 
approximately equal molar amounts of lipids and proteins. The composition and 
organization of the human erythrocyte membrane shown in figure 1, is briefly described 
in the following sections (Tse and Lux, 1999; De Rosa et al., 2007; Daniels, 2007).  
 
1.1.1. Membrane lipids 
 
Membrane lipids include phospholipids, glycolipids and cholesterol, which are arranged 
as a bilayer. The glycolipids and choline phospholipids are mostly oriented towards the 
outer surface of membrane while amino-phospholipids are more concentrated on the 
cytoplasmic surface. Cholesterol is found between the phospholipid molecules. The 
relative amounts of cholesterol and phospholipids are responsible for the fluid properties 
of the erythrocyte membrane (Deuticke, 1982). 
 
1.1. 2. Membrane proteins 
 
Erythrocyte membrane proteins are divided into two classes of integral and peripheral 
proteins depending on their relation to the lipid bilayer.  
The peripheral proteins which are, termed membrane cytoskeleton, are located below 
the cytoplasmic surface of lipid bilayer and play an important role to stabilize of bilayer 
integrity and control the cell shape of erythrocytes. The most prominent component of 
the erythrocyte cytoskeleton is spectrin. Two isoforms of spectrin, alpha (260 kDa) and 
beta (225 kDa) have been identified. These two form a loosely wound helix which form a 
tetramer. The spectrin tetramers are organized into a meshwork that is fixed to the 
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membrane by the protein ankyrin (Branton et al., 1981). Ankyrin (215 kDa) binds to 
spectrin in the membrane skeleton and a site on the cytoplasmic domain of Band III 
(Davis and Bennett, 1990). 
Glycophorin A is the major contact or receptor membrane polypeptide that also spans 
the lipid bilayer (Anderson and Lovrien, 1984; Chasis et al., 1985). It is suggested that 
the blood group determinants and possibly other biological receptor sites have been 
localized on the extracellular portion of glycophorin A. The other glycophorins (B and C) 
are present in smaller amounts on the erythrocyte membrane and are suggested to be 
associated with the membrane skeleton (Mueller and Morrison, 1981). 
Protein 4.1 has been shown to associate with cytoplasmic domains of glycophorin A 
(Anderson and Lovrien, 1984; Anderson and Marchesi, 1985), the Band III (Pasternack 
et al., 1985), and phosphatidylserine in the lipid bilayer (Cohen et al., 1988).  
 
Integral proteins contain a quite high number of membrane transporters and channels, 
the major species being the anion exchange protein, Band III. All of the integral proteins 
share a typical structure with 6 to 13 transmembrane domains, with both termini inside 
the cytosol and with an N-glycan on one of the external loops. Most other major 
membrane transporters are apparently essential for maintaining a stable erythrocyte cell 











Figure 1. The erythrocyte membrane organization. The integral membrane proteins like Band III and 
glycophorin are connected to the spectrin skeleton network via the bridging proteins, ankyrin, and protein 
4.1. (Modified from De Roza et al., 2007). 
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1.1.3. Erythrocyte surface proteins 
 
The external membrane of the human erythrocytes contains the proteins which either 
cross the lipid bilayer or are anchored to it through a lipid tail. These proteins are divided 
into different categories based on their functions: membrane transporters; adhesion 
molecules and receptors; enzymes; blood groups and structural proteins which link the 
membrane with the membrane skeleton (Viitala and Järnefelt, 1985; Daniels, 2007). 
 
1.1.4. Membrane transporters and channels 
 
Membrane transport proteins are integral proteins which facilitate the transfer of ions 
and molecules across the biological membranes. These proteins play key roles in cell 
life including the uptake of nutrients and removal of metabolic waste products as well as 
maintenance of electrochemical gradients (Deuticke, 2003). 
The membrane transport proteins are divided into two major classes: transporters and 
channels. Transporter proteins, also referred to as carrier proteins, bind to the specific 
solute and undergo a series of conformational changes in order to transfer the bound 
solute across the membrane. In contrast, protein channels do not bind the solute; they 
provide the pores across the lipid bilayer which allow the specific solute pass through 
the membrane. All channels and most of the transporters facilitate the transport of 
solutes passively based on the concentration or electrical gradient, while active transport 
which is always mediated by transporters needs a source of metabolic energy like ATP 
hydrolysis. 
Different types of membrane transporters have been identified on the erythrocyte 
membrane including the Cl-/HCO3- exchanger (Band III ; AE1), water and glycerol 
channels( Aquaporin 1 and 2); the Na+ and Ca2+ pump, the Na+ (K+)/H+ exchanger, the 
Na+K+2Cl- and KCl co-transporter, choline, monocarboxylate, glucose, different amino 
acid and nucleoside carriers (Ginsburg and Kirk, 1998; Kirk , 2001; Bernhardt and Ellory,  
2003). All membrane transporters detected in mature erythrocytes are synthesized early 
in erythrocyte differentiation, as the mature erythrocyte lacks the necessary machinery 
for protein synthesis.   
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1. 2. The membrane of the P. falciparum infected erythrocytes 
 
The erythrocytic stage of the life cycle of the malaria parasite is responsible for the most 
important clinical symptoms and pathology of acute and severe malaria disease. As the 
infected red blood cells ruptures and releases parasites, the patient typically develops a 
shaking chill followed by a high fever, the classical signs of the uncomplicated malaria 
which is directly associated with the intracellular development of the parasite in 
erythrocytes (Miller et al., 2002; Weatherall et al., 2002). Because of the high metabolic 
activity of the parasite during the intra-erythrocytic stage of the life cycle, the parasite 
carries out various alterations and conformational changes relating to the uptake of 
nutrients or survival in the host cell.   
 
1. 2.1. The malaria parasite Plasmodium falciparum 
 
P. falciparum is the causative agent of the most lethal form of human malaria which is 
estimated to be responsible for more than 300 million cases of clinical disease and more 
than 1 million deaths per year (Carter and Mendis, 2002; Snow et al., 2005). About 80% 
of malaria deaths are in sub-sahara Africa and among children under five years and 
pregnant women (WHO, 2005). In addition, malaria endemic countries have lower rates 
of economic growth (Sachs and Malaney, 2002, Malaney et al., 2004). 
 
1.2.1.1. Parasite Life Cycle 
 
Plasmodium species have a complex life cycle that alternates between a vertebrate host 
and an insect vector. The parasites are injected into the bloodstream of the human host 
by the bite of an infected female Anopheles mosquito. The parasites rapidly disappear 
from the bloodstream and invade hepatocytes in the liver. During the next 10-15 days, 
the parasite matures, and differentiates within hepatocytes, and undergoes several 
rounds of asexual division which produce thousands of infective merozoites that are 
released into the bloodstream. These merozoites invade host red blood cells where they 
undergo a process of growth followed by shizogony (asexual division) to form 6–32 
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daughter merozoites over a period of 48–72 h depending on the species. When the 
daughter merozoites are fully mature (the schizont stage), the infected red blood cell 
(IRBC) ruptures and the cycle begins again with the invasion of erythrocytes. A small 
proportion of the intracellular parasites undergo differentiation into male and female 
gametocytes, which may then be taken up in a mosquito blood meal, where they are 
released from the erythrocytes and fuse to form a zygote. The zygote then develops into 
a motile form, called the ookinete; this penetrates the mosquito's gut wall and develops 
into an oocyst which undergoes sprogony and produces a large number of infective 
sporozoites in the salivary glands of the mosquito (Miller et al., 2002; Bannister and 
Mitchell, 2003).  
 
1. 2.1. 2. Alteration of the host plasma membrane 
 
During the intra-erythrocytic development, the parasite induces a number of alterations 
in the host cell including the rearrangement and modification of host membrane proteins 
and lipids, insertion of the parasite proteins into the cell membrane of erythrocytes, an 
increase in the rigidity of the cell, increased permeability and alterations in metabolite 
transport (Reviewed by: Craig and Scherf, 2001). These alterations enable parasites to 
survive within the erythrocytes; they facilitate the acquisition of nutrients by the parasites 
and the release of waste products to the surrounding environment. Some of the induced 
changes protect the parasite against the immune system of the host by adhesion, 
sequestration and antigenic variation (Deitsch and Wellems, 1996).  
 
One of the most prominent ultra structural changes of the surface of infected 
erythrocytes is the electron-dense protrusions structures called knobs (Figure 2). It has 
been shown that knobs on the surface of infected erythrocytes act as attachment points 
of parasitized cells to the vascular endothelium (Aikawa, 1971 and 1996). During the first 
24 h of the P. falciparum asexual cycle, infected erythrocytes are found in the peripheral 
circulation, but during the second 24 h, the parasitized cells adhere to the endothelial 
cells and can sequester in capillary and post-capillary venules of different organs 
(Turner et al., 1998; Deitsch and Wellems, 1996). It has been reported that 
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cytoadherence is a parasite response to the ability of the host spleen to destroy infected 
erythrocytes (Deitsch and Wellems, 1996). Cytoadherence has an important role in 
parasite survival and pathology of the disease.  
 
It has been shown that parasite proteins are associated with the knobs (Deitsch and 
Wellems, 1996). The P. falciparum erythrocyte membrane protein-1 (PfEMP1) which 
mediates adhesion of infected erythrocytes to host endothelial cells is one of the 
parasite proteins which are found in knobs structure (Su et al., 1995; Smith et al., 1995; 
Kyes et al., 2001). Duffy binding ligand (DBL ) domains of PfEMP1 molecules are able to 
attach to different specific receptors on the surface of endothelial cells including 
thrombospondin (TSP) (Roberts et al.,1985), ICAM-1 (Berendt et al., 1989), VCAM-1 
(Ockenhouse et al., 1992), E-selectin, Chondroitin sulphate A (Rogerson et al., 1995), 
CD31 (Treutiger et al., 1997), and CD36 (Barnwell et al., 1989). It has been shown that 
PfEMP1 is localized to the Maurer's clefts (Wickham et al., 2001), the knobs (Roberts et 
al., 1992; Su et al., 1995; Smith et al., 1995; Kyes et al., 2001) and associates with the 
infected erythrocyte membrane (Waterkeyn et al., 2000). Mechanism of trafficking 
(Newbold and Marsh,1990; Baruch et al.,1995; Su et al,1995; Smith et al.,1995; 
Wickham et al., 2001; Marti et al., 2005 ; Knupfer et al., 2005), insertion and topology of 
PfEMP1 have been well studied (Kriek et al., 2003; Papakrivos et al., 2005). The C 
terminal domain (ATS domain) interacts with the binding motif of KAHRP (Waller et al, 
1999 and 2000), actin, spectrin and band 4.1 to anchor the protein in the red blood cell 
membrane (Oh et al, 2000; Voigt et al., 2000). 
 
Further parasite proteins inserted into the membrane of the host cell, possibly also 
playing a role in antigenic variation, and thus can be classified as major virulence 
factors. Some of these proteins which are exposed on the surface of infected 
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RIFINS. The repetitive interspersed family of genes (rif), expressed at early trophozoite 
stage, were characterized as encoding potential variant antigens (Cheng et al., 1998; 
Kyes et al., 1999). They encode a group of 30-45 kDa proteins which were initially 
identified as “rosettin” because they are associated with the rosetting phenotype 
(Helmby, et al., 1993). The exposure of RIFINS on the surface of infected erythrocytes 
was studied using surface radiolabelling of infected erythrocytes (Fernandez et al., 
1999) antibody detection and immunofluorescence data (Kyes et al., 1999).  
 
STEVOR. The sub-telomeric variant open reading frame (stevor) encodes a family of 30-
40 kDa proteins. These proteins have been shown to be localized in Maurer’s clefts 
(Kavirante et al., 2002; Przyborski et al., 2005) and on the surface of the infected 
erythrocyte (Blythe et al., 2004). It is proposed that STEVOR proteins based on the 
structure, cellular localization and expression patterns in different stages of parasite 
development have a multifunctional role in the parasite lifecycle (Blythe et al., 2004). 
 
SURFIN. The proteomic analysis of released peptides after trypsination of exposed 
protein on the surface of infected erythrocytes identified a new high molecular mass 
(286 kDa) protein encoded by surfin genes. Surfin is a polymorphic antigen that 
colocalizes with PfEMP1 and RIFINs and is present at both the infected erythrocytes 
and merozoite surface. SURFIN is suggested to be involved in the invasion of 












Figure 2. Parasite induced alterations in infected erythrocytes. During the erythrocytic development, 
the malaria parasite induces significant alterations in the cytosol and on the surface of the host cell that 
enable it to survive and proliferate in the host.RBC,red blood cell; PV, Parasitophorous vacuole ; MC, 
Maurer´s clefts; K, Knobs; PPM, Parasite plasma membrane (Nyalwidhe et al., 2003). 
 
 
 1. 2.1. 3. Novel Permeation Pathways (NPPs) 
 
Upon infection of the erythrocytes, the membrane of infected cells shows an unusually 
high permeability to a variety of solutes which are normally excluded from intact 
erythrocytes (Kunter et al., 1983, Ginsburg et al., 1985). The phenomenon which is 
referred to as “novel permeation pathways” (NPPs) (Ginsburg et al., 1983; Kirk et al., 
1999) is induced 10-20 hours after erythrocyte invasion and is detectable through the 
parasite development (Kunter et al., 1983, 1985; Saliba and Kirk, 2001).  
The NPPs are responsible for the increased permeability of infected erythrocytes 
membrane to the low molecular weight solutes including monosaccharides (Ginsburg et 
al.,1983 ,1985 ; Kirk et al.,1994, 1996), amino acids (Erfold et al.,1985; Ginsburg et al., 
1985; Kirk et al., 1994, 1996) peptides (Atamna and Ginsburg, 1997; Saliba and Kirk, 
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1998), nucleosides (Upston and Gero, 1995), anions (Cranmer et al.,1995; Kirk et al., 
1993),cations (Staines et al., 2000) vitamin pantothenic acid (Cranmer et al., 1995; Kirk 
et al., 1993) and monovalent organic ions like choline (Kirk et al., 1991; Staines and 
Kirk, 1998). The NPPs act as a channel with a general preference for anions and solutes 
over cations (Desai et al., 2000; Kirk, 2001). The typical anion channel blockers like 
furosomide,5-nitro-2(-3-phenylpropylamino)benzoic acid (NPPB) ( Kirk et al., 1994), 4,4'-
Di-isothiocyanatostilbene-2,2'-disulfonic acid ( DIDS )( Kirk and Horner,1995a and b) 
and 4,4'-diisothiocyano-2,2'-dihydrostilbene disulfonic acid (H2DIDS) (Breuer et al., 
1987) can inhibit the pathway. It has been shown that infected erythrocytes are 
permeable to the different membrane impermeable biotin derivatives and that 
permeability can be inhibited by these biotin derivates (Nyalwidhe et al., 2002; 
Baumeister et al., 2003).  
The function and morphological characterization of NPPs has been well studied, but the 
origins and numbers of induced NPPs on erythrocyte are still under investigation (Kirk, 
2004; Staines et al., 2007). 
Different electrophysiological studies including whole-cell patch-clamp and hemolysis 
experiments on infected cells indicated the increased conductance of parasitized 
erythrocytes (Desai et al., 2000; Egee et al., 2002; Huber et al., 2002a and b; Duranton 
et al., 2003, 2004; Staines et al., 2003, 2004), but it is still unclear, whether the NPPs 
are mediated by the parasite-derived proteins which are inserted into the erythrocyte 
membrane or they are endogenous protein which induced on the host membrane 
proteins upon  infection. The current proposed models for the NPPs are composed of 
several channel types and pores (Staines et al., 2007). 
The first direct physiological evidence for the involvement of a novel anion channel in 
NPPs activity was provided by the data from whole and single channel recording of 
infected and non-infected erythrocytes. In this study a voltage-dependent small ion 
channel on the surface of infected RBC (plasmodium surface anion channel (PSAC)) 
was identified which presents at about 1000-2000 copies on trophozoite stage of 
infected erythrocytes and suggested to account for the increased permeability of 
infected erythrocytes (Desai et al., 2000; Alkhalil et al., 2004). Failure to induce PSAC-
like activity in non-infected erythrocytes does not definitively exclude a modified host 
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protein which may be involved in NPPs. Several studies have reported that some 
stresses (like oxidation) can induce NPP-like pathway in non-infected erythrocytes. 
Based on these findings, the investigators suggested that possible NPP pathways are   
derived from host cell proteins (Duranton et al., 2002; Egee et al., 2002; Huber et al., 
2002; Verloo et al., 2004, Bouyer et al., 2006). 
To investigate this possibility, the malaria-induced anion channel was compared with an 
endogenous anion channel in infected erythrocytes using the patch clamp approach, the 
data provided evidences for existence of three distinct anion channels including an 
intermediate, a small and an outwardly rectifying large anion channel (Egge et al., 2002, 
Boyer et al., 2006) which can be activated by either, protein kinase A (PKA)/ATP or 
membrane deformation. Based on these findings, it is thought that the mechanism which 
the parasite uses to induce the NPPs in host membrane may involve phosphorylation 
(Egg et al., 2002; Descherf et al., 2004). 
Furthermore, since the parasite induces high oxidative stress in the host erythrocyte 
(Atamna and Ginsburg, 1993, 1997), increased membrane permeability is suggested to 
result from oxidative alteration of the host cell membrane upon infection. To confirm this, 
the membrane permeability in infected erythrocytes and in non-infected erythrocytes that 
were oxidised were measured using whole-cell patch recording and iso-osmotic lysis 
(Huber et al., 2002). At least four parasite induced channels were reported including 3 
endogenous anion channels which can be activated in the host cell by oxidation (Huber 
et al., 2002, 2004; Staines et al., 2003). In accordance with these previous experiments, 
a previous study has shown that NPP activity can be inhibited by protease treatment of 
infected cells, suggesting that a protein within the erythrocyte plasma membrane 
mediates NPP activity. However, this activity recovered upon reintroducing the infected 
erythrocytes to cell culture, and reappearance could be blocked by treatment of the 
infected erythrocytes with the fungal metabolite brefeldin A (BFA), which blocks 
secretion of parasite encoded proteins to the host cell (Baumeister et al., 2006). These 
data, whilst supporting the notion that an erythrocyte plasma membrane protein is 
involved in NPP activity however also show that parasite encoded protein also play an 
important role in NPP, either by directly transporting NPP substrates, or by activating 
endogenous erythrocyte membrane channels. 
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A variety of membrane transporters have been identified on the erythrocyte membrane 
such as the Cl-/HCO3- exchanger (Band III; AE1), the Na+ and Ca2+ pump , the Na+ 
(K+)/H+ exchanger, the Na+K+2Cl- and KCl co-transporter, choline, monocarboxylate, 
glucose, amino acid and nucleoside carriers (Ginsburg and Kirk, 1998), of which Band 
III, as a major anion exchanger shares some properties with NPPs anion channels and it 
has been proposed to be one of the candidate proteins for the NPPs (In: Kirk, 2001) 
(Huber et al., 2002; Thomas et al., 2004). Band III acts as anion channel with 
permeability to a range of anionic and electroneutral organic solutes (Fievet et al., 1995). 
Moreover, the specific NPPs inhibitor like DIDS and H2DIDS can block the anion 
transport function of Band III (Okubo et al., 1994; Winograd et al., 2004). It has been 
reported that oxidative stress induces a variety of modification in the structure of Band 
III; these include phosphorylation (Zipser et al., 1997), clustering (Dumaswala et al., 
1999; Hornig and Lutz, 2000) and methyl esterification (Ingrosso et al., 2000). Similar 
alterations on Band III also occur upon malaria infection (Giribaldi et al., 2001).  
It has been shown that Band III undergoes cleavage in the infected erythrocytes 
(Sherman and Wingorad, 1990; Crandall and Sherman, 1991,1994) and this modified 
form of Band III protein is suggested to be involved in NPPs (Kirk, 1994). Baumeister et 
al., 2006 studied the effect of protease treatment on the Band III protein and on NPP 
activity in infected erythrocytes. The data showed that both Band III and putative NPPs 
were resistant to trypsin treatment and susceptible to chymotrypsin cleavage but the 
effect of chymotrypsin on the NPPs activity was concentration and time dependent. 
Chymotrypsin treatment of intact erythrocytes at 37°C for more than 10 min resulted in 
the complete cleavage of Band III but has no effect on NPPs activity under same the 
conditions. Based on these findings the authors concluded that induced NPPs activity 
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1. 3. Biotinylation of proteins 
 
Since parasite induced alterations (due to exposed parasite proteins on the surface of 
infected erythrocytes or conformational changes of erythrocytes membrane protein upon 
infection) can be expected to be in low amounts in order to avoid of host immune 
system, a sensitive method has to be established and used to detect them. Biotin 
labelling is one of the most commonly used tools for proteins study. Because of its small 
molecular weight and steric volume, biotin residues can react with many different 
molecules (Wilchek and Bayer, 1988 and 1990) without inducing any alteration in their 
biological activity. The labelled molecule can be effectively affinity purified using avidin 
or its bacterial alternative streptavidin. The biotin-avidin complex is the strongest known 
non-covalent interaction between protein and ligand with extraordinary affinity (Ka= 1015 
M-1). 
Biotinylation has been used to characterize cell wall proteins of different organisms  
such as Borrellia burgdorfi (Luft et al., 1989), Saccharomyces cerevisiae (Cappellaro et 
al 1998), Candida albicans (Casanova et al., 1992), Helicobacter pylori (Sabarth et al., 
2002), Shistosoma mansoni (Braschi and Wilson, 2006) and Cryptosporidium 
neoformans (Foster et al., 2007). Scheurer et al., (2005) used different biotinylation 
reagents and 2D peptide mapping to identify and quantify the membrane proteins of 
human umbilical vein endothelial cells cultured in normoxic and hypoxic condition. 
Different biotin derivatives have been used to label the proteins on the surface of P. 
falciparum infected erythrocytes (Nyalwidhe et al., 2002; Baumeister et al., 2003; 
Florens et al., 2004; Winter et al., 2003, 2005; Sharling et al., 2007; Azimzadeh et al., 
2007). It has been shown that the membrane impermeable sulfo-NHS-LC biotin 
derivative is internalized by infected erythrocyte probably through NPPs and that their 
uptake and subsequent biotinylation of internal proteins can be prevented using NPPs 
inhibitors (Nyalwidhe et al., 2002; Baumeister et al., 2003). Sulfo-NHS-LC-biotin was 
used to biotinylate permeabilized infected erythrocytes to specifically label soluble 
proteins in the parasitophorous vacuole (Nyalwidhe et al, 2002; Nyalwidhe and 
Lingelbach, 2006). Recently, sulfo-NHS-LC-biotin was used to probe the protein 
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structure and conformational changes of Band III on the surface of infected erythrocytes 
(Azimzadeh et al., 2007). 
The structure of sulfo-NHS-LC-biotin, which has been used in this current study, 
consists of an active ester group, N-hydroxysuccinimydyl (NHS), which reacts in 
aqueous solution with primary amines of proteins, particularly with the N terminus and 
the epsilon amino group of lysine residues at a neutral pH or higher. A novel stable 
amide bond is formed and the biotin moiety is covalently attached to the respective 
amino group (Figure 3). In addition, the sulfo-NHS-LC-biotin contains a sulfonyl moiety 
(NaSO3) which is hydrophilic and this group inhibits the ability of these derivatives to 
permeate biological membranes. These derivatives are used to selectively label surface 
proteins in different organisms. The sulfonyl group permits the solubilisation of biotin 
derivative in aqueous buffers and the experiments can be conducted under physiological 
conditions. The biotin and reactive ester group are linked by a spacer arm. The spacer in 
LC-biotin is a hexanoate link (LC=long chain) 22.4 Angstroms in length. This spacer 
reduces steric hinderance and facilitates binding of biotinylated proteins to avidin to 
increase the sensitivity of detection.  
Although amino acid residue modifications by specific tags or cross-linkers in 
combination with mass spectrometry have been used as tools for probing the tertiary 
structure of proteins (Bennet et al., 2000; Young et al., 2000; Back et al., 2002), the use 
of biotin derivatives has additional advantages: the labelled proteins can be readily 
visualized before analysis; the labelled peptides can be affinity-enriched; and several 
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Figure 3. The sulfo-NHS-LC biotin derivative reacts with primary amines forming an amide bond. In 
proteins and peptides, primary amines and the epsilon amine of lysine which can react with NHS ester on 
the derivatives (modified from Pierce).  
 
 
1. 4. Mass spectrometry  
 
Mass spectrometry is a sensitive and accurate analytical method to determine the 
molecular mass and molecular structure of compounds. In addition, it is an accurate and 
sensitive technique for the identification and quantitation of different biological molecules 
such as proteins and nucleotides (Glish and Vachet, 2003). The mass spectrometer 
consists of three main components: an ionization source, a mass analyser and a 
detector which measure the mass to charge ratio (m/z) of ions under high vacuum. 
There are two available ionization sources for mass spectrometer: Electrospray (ESI) 
(Yamashita and Fenn, 1984) and Matrix-assisted laser desorption ionization (MALDI) 
(Karas and Hillenkamp, 1988). 
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MALDI is a soft ionization method that is used to generate gas phase protonated 
molecules including peptides for mass spectroscopy. The proteolytic peptides are mixed 
with a matrix compound such as alpha-cyano hydroxycinnamic acid at an approximately 
1000 fold molar excess. The mixture is placed on a metallic slide or target and the 
mixture is allowed to dry. The slide is then inserted into a vacuum chamber and 
irradiated by nanosecond laser pulses. The small matrix molecules absorb the energy, 
move away from the target and carry the intact analyte molecules into gas phase 
(Hillenkamp et al., 1990). As this happens, a proton is transferred from the matrix to the 
peptides in a process that is not yet fully understood (Karas et al., 2000). All positively 
charged polypeptides with their different masses get vaporized and are accelerated in 
an electric field with the help of a high voltage grid to the same kinetic energy and they 
enter a flight tube of TOF (time of flight) mass analyser where the light ions that have a 
higher velocity arrived at the detector before the heavy ones. The recorded time of flight 
is used to calculate the masses of the ions in m/z. For most analytical applications the 
positive mode is used but negative mode operation is also possible. Negative ionisation 
that occurs through the generation of deprotonated ions can be used for the analysis of 
oligonucleotides and oligosaccharides. Several technical developments including 
reflectron tubes (Cornish and Cotter, 1993) and pulsed extraction (Jensen et al., 1996) 
have been used to obtain a better and higher mass accuracy. The set of measured 
masses of generated peptides from protein digest are used to identify the protein by a 
method which is called peptide mass fingerprints (PMF). The experimental mass profile 
from spectrum is searched and matched against the theoretical mass from in silico 
digestion of the different protein amino acid sequences in a database.  
Different factors are important for the successful protein identification; these include 
MALDI peak mass accuracy, the relation between assigned and unassigned peaks in 
spectrum and the size of databases (Perkins et al., 1999). To avoid of possibility of false 
positive results, the protein identification may be done with peptide fragmentation data 
by tandem mass spectrometry in the process known as MS/MS. Peptide ions which are 
selected with a first mass analyser, are fragmented by collision induced association 
(CID) with argon or helium under low energy conditions and measured with a second 
analyser. The fragmentation occurs principally at the peptide amide bonds. Two types of 
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ions are produced by fragmentation: y-ions with intact C-terminus and b-ions with intact 
N-terminus (Biemann, 1992). The measured mass of fragments are checked against the 
masses of amino acids and finally matched to amino acid sequences to identify peptides 
and proteins with the help of different programs including MASCOT (Perkins et al., 1999) 
or SEQUEST (Sadygov et al., 2004) to search in protein databases like SwissPort and 
NCBInr. 
In addition to protein identification, mass spectrometry is powerful tool to determine post-
translational modifications (PTMs). If the primary amino acid sequence is known in 
advance, mass spectrometry can be used to detect the differences from the expected 
protein mass that is produced by modifications of its primary structure. This mass shift is 
the basis of the detection of PTM by mass spectrometry. In addition, the sites of these 
modifications can be localized by using either tandem mass spectrometry of the intact 
proteins, peptide mass fingerprinting following proteolysis, or a combination of the two 
techniques. Amino acid residues modification by specific tags and crosslinkers in 
combination with mass spectrometry have been used for probing the tertiary structure of 
proteins (Bennett et al., 2000; Young et al., 2000; Back et al., 2002; Huang et al., 2004,  
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1. 5. Study of conformational changes in model protein 
 
In this study, biotinylation using the sulfo-NHS-LC biotin derivative in combination with 
mass spectrometry analysis has been used to probe conformational changes in the 
structure of two soluble proteins bovine serum albumin (BSA) and carbonic anhydrase II 
(CA II) and that of Band III, an integral membrane protein with multiple trans-membrane 
domains. 
 
1. 5.1. The structure and properties of bovine serum albumin (BSA) 
 
Serum albumin is a highly soluble multidomain protein with mass of 69 kDa which is 
found in every tissue. It is the most abundant plasma protein with a concentration of 5 
mg/100ml and contributes 80% of colloid osmotic blood pressure (Carter and Ho, 1994). 
Serum albumin plays an important role in maintaining of blood pH and in the transport of 
multiple substances within the bloodstream including free fatty acids, phospholipids such 
as lysophosphatidic acid (LPA), steroid-based hormones, prostaglandins, and heavy 
metals (Peters, 1985; Carter and Ho, 1994 ). It is also capable of binding a broad range 
of metabolites, drugs and organic compounds (Koh et al., 1998; Iglesias et al., 1999). 
It was shown that albumin is involved in the sequestering oxygen free radicals and 
inactivating various toxic lipophilic metabolites such as bilirubin (Emerson, 1989).  
Albumin is synthesized initially in the liver as pre-proalbumin in mammals. After removal 
of the signal peptide, proalbumin undergoes a further processing and it loses six-
residues from the new N-terminus (Peters and Anfinsen, 1950).  Albumin is released into 
circulation and has a half-life of 19 days (Carter and Ho, 1994).  
The structure and chemistry of albumin has been studied using different methods 
including hydrodynamics, low-angle X ray scattering, fluorescence energy transfer, 
electrophoretic methods, NMR, IR, UV, Raman spectroscopies and mass spectrometry 
(recently reviewed in detail : Carter and Ho, 1994). Amino acid sequences 
determination, molecular structure and ligand binding properties of the albumin family 
have been described based on the study of the human serum albumin (HSA) (Carter 
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and He, 1990; Curry et al., 1998; Sugio et al., 1999). Hydrodynamic experiments (Wright 
and Thompson, 1975) and low-angle X-ray scattering (Bloomfield, 1966; Bendedouch 
and Chen, 1983) showed that serum albumin was shaped like an oblate ellipsoid with 
dimensions of 140 × 40Å. Based on these findings, albumin was suggested to have a 
cigar shaped three domain model (Carter and Ho, 1994), but electron microscopy (Luft 
and Lorscheider,1983) and subsequent studies using resonance energy transfer 
methods (Hagag et al.,1983) and  NMR (Bos et al,1989) indicated that such a structure 
was unlikely and suggested that albumin must be folded more having a U shaped 
molecule with dimension of 80 Å, which was referred to as heart-shaped structure. 
As shown in figure 4, a high percentage similarity has been shown between bovine 
serum albumin (BSA) and HSA sequences; these proteins share 76% amino acid 
sequence homology (Peters, 1985). Sequence analysis data indicate that human serum 
albumin is composed of 585 amino acids (McGilivray et al., 1979; Reed et al., 1980). 
The amino acid sequence of BSA has been determined by the Edman degradation 
method (Reed et al., 1980). Automated sequencing and tandem mass spectrometry 
confirmed the absence of three amino acids in BSA in comparison with HSA (Hirayama 
et al., 1990). The HSA amino acid composition is characterized by high percentage of 
charged amino acids, lysine arginine, aspartic and glutamic acid and low percentage of 
tryptophan and methionine (Carter and Ho, 1994). In addition, albumin has an unusually 
high content of 35 cysteine residues containing a free sulfhydryl group (Sugio et al., 


































Figure 4. The comparison of primary structure of HAS and BSA. The domain structure of BSA was 
shown based on the HSA homology. Two proteins share 76% amino acid sequence homology. The 3D 
structure of BSA was generated by 3d jigsaw software using the HAS sequence. 
 
 
The primary structure of HSA consists of three homologous domains, domain I (residues 
1–195), domain II (196–383) and domain III (384–585) which are topologically identical 
and very similar in three-dimensional structure (Sugio et al., 1999). Each domain in turn 
is the product of two subdomains (A and B) (Carter and He,1990; He and Carter,1992) 
which further divides into nine loops (L1-L9) and are cross linked by 17 disulphide bonds 
(Peters, 1985). The disulphide bonds are located almost between helical segments 
(Carter and Ho, 1994), they are not accessible to the solvent and protected from 
reducing agents at neutral pH (Katchalski, 1957). The conformations of the disulphides 
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bonds are primarily gauche-gauche-gauche and Cß1-S1-S2-Cß2, with torsion angles 
clustering around ± 80° (Carter and HO, 1994). The structure and conformation of the 
disulphide bonds is responsible for the stability of albumin under harsh experimental 
conditions like high temperature treatment (Carter and HO, 1994; Pico et al., 1997). 
The secondary structure of human serum albumin has been well studied using X-ray 
crystallography (Spector, 1975; He and Carter, 1992; Sugio et al., 1999; Curry et al., 
1998), biochemical labelling and NMR spectroscopy (Cistola et al., 1987; Hamilton et al., 
1991).  Albumin structure is largely (67%) alpha helical, the rest of the protein turns and 
extended between subdomains with no beta sheets, forming the heart shape molecule. 
Each of the domains is composed of 10 helices, h1 - 6 for sub-domain A and h7 - 10 for 
sub-domain B (Peters, 1985). All sub-domains share a common helical motif. The A sub-
domains consist of the three helix bundle on the C-terminal side and one smaller 
disulfide double loop to form a small globin-like structure that is linked by four disulfide 
bridges. The B sub-domain supplements the helical motif on the N-terminal side with 
extended polypeptide to form a folding structure of a simple up-down helical bundle. 
These sub-domains assemble through hydrophobic helix packing interactions involving 
h2, h3 and h8 (Carter and Ho, 1994). In addition, the sub-domains are joined together 
by stretches of flexible extended polypeptide (IA-IB, 106-119; IIA-IIB, 292-315; IIA-IIIb, 
492-511) (Curry et al., 1998). Domains I and II and domains II and III in turn are 
connected through helical extensions of h10 (I) - h1 (II) and h10 (II) - h1 (III), creating the 
two longest helices in albumin (Carter and Ho, 1994). 
Structural alterations and conformational flexibility of albumin at thermal denaturation 
have been previously studied. It was shown that albumin can be heated to 60°C for 10 
hours without deleterious effects (Pico et al., 1998). The stability of the albumin depends 
on the protein concentration and the free-SH groups in the protein structure (Wetzel et 
al., 1980; Ross and Shrake, 1988). Heating of albumin leads to two stages of structural 
changes in the protein structure. The first step is heating up to 65°C that leads in 
reversible changes. The subsequent heating is irreversible but does not necessarily 
result in a complete destruction of the protein structure (Wetzel et al., 1980). It has been 
shown that the heating above 65°C causes a partial loss of the alpha helix and induces 
the beta-sheet in the albumin structures which are amplified on cooling (Wetzel et al., 
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1980). The comparison of the chemical and thermal denaturations of albumin indicated 
different structurally unfolded states of the protein. It has been observed that chemical 
denaturing using guanidine and urea induces a randomly coiled conformation in the 
unfolded state of albumin structure, while thermal denaturation produces a molten 
globule state and the aggregation of the protein (Farrugia and Pico, 1999).  
Recently, the conformational changes of tertiary structure of BSA (Huang et al., 2006) 
and HSA (Huang et al., 2005) was probed using different lysine specific cross linking 
reagents with various spacer arm length before analysis by electrospray tandem mass 
spectrometry. The obtained distance between lysine residues generate the information 
about the 3D structure of the albumin proteins. In addition, the changes in the 
conformation of albumin structure induced by fatty acid binding were detected based on 
the changes in cross-linked peptides by MS/MS (Huang et al., 2005).  
 
1. 5. 2. The structure and properties of Carbonic anhydrase II (CA II) 
 
The carbonic anhydrase (CA) is a ubiquitous enzyme found in all animals, plants, 
archaeo and eubacteria, (Supuran and Scozzafava, 2001; Supuran et al., 2003). The 
structure and function of CA has been extensively investigated (Kannan et al., 1975; 
Håkansson and Wehnert ,1992; Håkansson  and Liljas, 1994; Lindskog, 1997). 
CA catalyses different physiological reactions, including the reversible hydration of CO2 
to bicarbonate (Pocker and Stone, 1967; Sly and Hu, 1995),, the hydration of certain 
aldehydes (Pocker and Meany,1965), and the hydrolysis of certain esters (Tashian et 
al.,1964). In animals, CA plays an important role in respiration by facilitating transport of 
carbon dioxide and is involved in the transfer and accumulation of H+ and HCO3- in 
organs of secretion (Maren, 1967). The CO2 generated by metabolism in all cells is 
removed from the body by red blood cells that convert most of it to bicarbonate for 
transport, then back to carbon dioxide to be exhaled from the lungs.  
There are three distinct evolutionary and structurally CA classes, α, β ,γ (Hewett-Emmett 
and Tashian 1996) which have no significant sequence homologies but all of them are 
zinc containing enzymes (Lindskog,1997). In contrast to CA β and γ, the mammalian 
isoenzymes CA α  have been well characterized by structural and mechanistic studies 
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(Christianson and Cox, 1999). Seven genetically α CA have been identified in human (I-
VII) which have different tissue distributions and intracellular localizations (Lindskog, 
1997). The amino acid sequences of the different human CA have been determined and 
are quite similar (Andersson et al., 1972; Lin and Deutsch, 1973a and b; Henderson et 
al., 1976; Lloyd et al., 1986; Okuyama et al., 1992; Nagao et al., 1993; Aldred et al., 
1991; Montgomery et al., 1991). 
The 29 kDa CA II protein consists of 259 amino acid residues in an one domain 
polypeptide which contains neither disulfide bonds nor free -SH groups and there is no 
evidence for formation of polymeric species (Håkansson et al., 1992; Arensson et al., 
1995; Lindskog, 1997). The crystal structure of CA II showed that protein has some 
helical structure and a dominating twisted β-sheet that extends throughout the entire 
molecule and divides it in two halves (figure 5) (Håkansson et al., 1992; Freskgård et al., 
1994; Arensson et al., 1995). Unlike the other larger proteins, which contain several 
structural domains, CA II appears to be folded in a single unit that includes the entire 
protein (Lin and Deutsch, 1973). Enzyme activity is due to the zinc atom which is near 
the bottom of a canonical intermolecular cavity and is coordinated to three histidine 












Figure 5. The secondary structure of bovine CA II. CA II is a single domain polypeptide contains some 
helical structure dominating twisted beta sheets. The 3D structure was generated by 3d jigsaw software. 
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The effect of temperature on the structure and activity of CA II has been studied 
(Lavecchia and Zugaro 1991; Sarraf et al., 2004). The thermal denaturation curve of CA 
has a classical sigmoid shape with melting temperature of 64.2°C. Only minor structural 
changes may be expected at this pre-transition temperature (Sarraf et al., 2004). It was 
shown that the heat treatment of CA II from 25°C to 40°C causes a decrease in the 
amount of β structures and an increase in the random coil structures. But from 40°C to 
52°C, the amount of helix is slightly decreased and there is an increase in the 
percentage of β structures. The authors suggested that the first decrease may be due to 
the lower stability of β structures comparing to helices (Sarraf et al., 2004). Chemical 
denaturation and conformational changes of CA II have been studied using guanidine 
chloride (Wong and Tanford, 1973; Henkens et al., 1982) and 2,2,2-Trifluoroethanol 
(TFE) ( Wei et al., 2006). It has been shown that the protein is fully unfolded by using 3M 
guanidine chloride to yield a random coil (Wong and Tanford, 1973) and refolds upon 
removal of the denaturing conditions to re-form the native structure (Yazgan and 
Henkens, 1972; Wong and Tanford, 1973). The zinc remains tightly bound to the fully 
denatured protein (Henkens et al., 1982). It has been reported that CA II undergoes a 
significant changes in the secondary structure when TFE is used at a concentration 
above 40 %( v/v) (Wei et al., 2006). 
The differences in the physical properties of BSA and CA II make them suitable model 
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physical properties BSA CA II 
Number of amino acids 583 259 
Molecular weight (Da) 69293.4 28982.5 
Theoretical pI 5.82 6.4 
Number of Lysine residues 60 18 
Number of Cysteine residues 35 0 
Number of disulphide bonds 17 0 
Sulphydryl group (SH) 1 0 
 
Table 1. The differences in the physical properties of BSA and CA II. The differences in the physical 
properties of BSA and CA II make them suitable model proteins to use in comparative analysis studies. 
 
1. 6. The structure and properties of Band III protein (Anion Exchanger 1, AE1) 
 
Anion-exchanger (AE) proteins facilitate the electroneutral exchange of Cl- for HCO3- 
across the plasma membrane of cells and contribute to regulation of intracellular pH, cell 
volume, bicarbonate metabolism and maintenance of intracellular chloride levels (Casey 
and Reithmeier, 1991; Jay and Cantely, 1986). The anion exchanger multigene family 
consists of four members (AE1-4), of which three have been identified and characterized 
(Kopito and Lodish, 1985; Tanner et al., 1988; Lux et al., 1989; Kopito, 1990; Gehrig et 
al., 1992; Schofield et al., 1994; Alper et al., 1991). The AE1-3 proteins share significant 
homology but they are found in different tissues (Alper et al., 1988; Bruce and Tanner, 
1999).  
The AE1 gene is expressed during erythropoiesis in both avian and mammalian 
erythroid progenitor cells. The erythroid AE1, also called Band III protein is the most 
abundant anion transporter in red blood cell (Frazar et al., 2003) with 1.2x106 copies per 
cell (Fairbanks et al., 1971) making up 25% of all red blood cell membrane proteins (Jay 
und Cantley, 1986). The protein is a homodimer but its tetramer has also been identified 
(Casey and Reithmeier, 1991, Wang et al., 1993). It was observed that 60% of protein 
exists as a dimer and 40% as a tetramer in erythrocytes membrane (Yu et al., 1975). 
The truncated form of AE1 is also found in the kidney; it is expressed in the basolaternal 
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membrane of alpha-intercalated cells of distal nephron and lacks the 65 amino acids at 
the N-terminal.  
The structure of Band III has been extensively studied using different approaches 
(Jennings and Anderson, 1987, Jay and Cantely, 1986). The 95 kDa Human Band III 
protein is a 911 amino acids polypeptide. The complete sequence of human Band III has 
been deduced from the cDNA sequence (Tanner et al., 1988; Lux et al., 1989). The 
sequence analysis of Band III protein revealed that the amino acid composition of Band 
III protein is highly hydrophobic and consisting of approximately 31% charged amino 
acid residues, 29% apolar amino acid residues; the rest are the residues which have 
intermediate polarity (Tanner and Boxer, 1972; Ho and Guidotti, 1975; Yu et al., 1975; 
Benga et al., 1991). It has been shown that polar amino acid residues including lysine, 
arginine, glutamic acid and histidine are essential in the structure of Band III for transport 
activity of the protein (Izuhara et al., 1989; Jennings and Anderson, 1987; Zaki, 1981; 
Garcia and Lodish, 1989; Passow et al., 1986; Okuba et al., 1994; Jin et al., 2003). 
Band III consists of two structurally and functionally distinct domains (Yu et al., 1975; 
Kopito and Lodish, 1985). The 43 kDa N-terminal domain (residues 1-359) is located in 
the cytosol and associated with peripheral and anchor proteins of the erythrocyte 
membrane (Rybicki et al., 1986). The 55 kDa C-terminal membrane spanning domain 
(residues 360-911) traverse the plasma membrane multiple times (Jennings, 1985; 
Zhang et al., 2000).  
The structural features of the cytoplasmic domain of Band III has been studied and 
analyzed using X-ray crystallography (Chang and Low, 2003), but the topology of the C-
terminus is not well established. Current models for the transmembrane (TM) 
organization of this protein are based on different studies including 
Cryoelectromicroscopy (Wang et al., 1993), NMR (Gargaro et al., 1994, Askin et al., 
1998), hydropathy analysis (Kopito and Lodish,1985), proteolysis( Kuma et al., 2002), 
antibody binding study (Wainwright et al.,1989) and N-glycosylation insertion 
mutagenesis (Tam et al.,1995; Popov et al., 1997; Popov and Reithmeir, 1999) and 
cysteine-scaning mutagenesis (Tang et al., 1998 ;Fujinage et al., 1999 and Zhu et al., 
2003). According to these studies, the membrane domains of Band III might span the 
membrane12 to14 times (Kopito and Lodish, 1985). The three proposed topology 
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models of Band III are shown in figure 6. There is a general agreement about the 
topology of first 9 transmembrane domains, but the topologies of the domains TM9 -
TM13 have not been conclusively determined. The topology of the 10th region is still not 
clear (Kanki, et al., 2002). Different experimental approaches indicate that this region is 
exposed to the extracellular (Fujinaga et al., 1999) or cytoplasmic side of the membrane 
(Kuma et al., 2002). Different studies have reported that the loops containing residues 
430-432, 551-562, 628-658, and 851-854 are exposed on the extracellular surface of 
erythrocyte (Steck et al., 1976; Popove et al., 1997; Fujinaga et al., 1999; Bruce et al., 
1994; Jarolim et al., 1998; Jennings et al., 1985; Cobbe et al., 1990). The region with 
high flexibility structure is located between amino acids 815-835 but no clear topology 
for this region was predicted (Zhu et al., 2002; Fujinaga et al., 1999). This region is not 
predicted to be a transmembrane region by conventional hydropathy analysis (Kopito 
and Lodish, 1985). It is suggested that this region can be exposed to face outside of cell 
under some circumstances (Zhu et al., 2002). It has been reported that synthetic 
monoclonal antibody corresponds to residues 813-824 can bind erythrocytes only after 
detergent treatment, suggesting that the epitope is not accessible at the extracellular 
surface normally (Wainwright et al., 1990). In contrast, the 812-827 region exposed as 
an extracellular antigen, when erythrocytes age (Kay and Lin, 1990). In addition, it has 
been reported that this region is also differentially recognized in non-infected and in P. 
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Figure 6. Proposed topology model for Band III protein with 12-14 transmembrane domains. The 
Band III protein is a transmembrane protein which is predicted to span the lipid bilayer 12 to 14 times. a) 
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Band III protein is known to undergo conformational changes upon malaria infection 
(Sherman et al., 2004). Confocal microscopy showed the induced reorganization in host 
membrane proteins and indicated increased aggregation (Giribaldi et al., 2001) and 
decreased mobility of Band III (Parker et al., 2004).  
It has been reported that Band III, together with PfEMP1 and thrombospondin, is 
associated with the adhesion of infected erythrocytes to endothelial cells (Crandall et al., 
1993; Lucas and Sherman, 1998). The adhesive domain of Band III including residues 
534-547 can bind to the anion exchange inhibitor DIDS, this sequence referred to DIDS 
binding domain (DBR) (Okubo et al., 1994; Winograd et al., 2004).  
In addition, the antibodies which were raised against synthetic peptides on putative 
exofacial loop 3 (amino acids 546-555) (Sherman et al., 2003) and loop 7 (amino acids 
821-834) (Crandall et al., 1994) of Band III, inhibit the cytoadherence. These monoclonal 
antibodies can identify the special epitope on the surface of infected erythrocyte but not 
in normal red blood cells. The ability of synthetic of Band III peptides to block the 
cytoadherence is called “pfalhesin” (Crandall et al., 1993). It is hypothesized that the 
pfalhesin and DBR sequence are cryptic in non-infected erythrocytes and are exposed 
during parasite growth (Sherman et al., 2003; Winograd et al., 2005). These sequences 
have some similarity to the senescent antigen amino acid composition in the Band III 
(Kay et al., 1990). 
It was reported that Band III may be the possible receptor for parasite proteins involved 
in the invasion of malaria parasite to erythrocytes. Recently, two non-glycosylated 
exofacial regions of Band III have been identified as a receptor binding the C terminal of 
merozoite surface protein 1(MSP1) during the invasion of parasites to erythrocytes. 
Amino acids 720-761 and 807-826 are identified as the core region of the Band III 
receptor which interacts with MSP1 (Goel et al., 2003). In addition, Band III has been 
shown to be a possible receptor for the of the parasite acidic-basic repeat antigen 
(ABRA) which located on the surface of malaria merozoite (Kushwaha et al., 2002). 
 
 
As it noted previously, there is some similarity between the properties of Band III and 
NPPs, this has provided reason for investigators to consider native Band III or its 
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modified form as one of the possible candidate proteins for the NPPs (In: Kirk, 2001; 
Huber et al., 2002a and b; Thomas and Lew, 2004).  It has been reported that Band III 
behaves as bifunctional protein with both anion exchange (Knauf and Rothstein, 1971; 
Jennigs, 1985) and swelling-activated osmolyte channel functions (Motais et al., 1997). 
A broad range of anionic and organic solutes can be transported by Band III (Fievet et 
al., 1995 and 1998). Furthermore, the anion transport and cell volume regulating activity 
of Band III can be blocked by specific NPPs inhibitor such as DIDS and H2DIDS (Okubo 
et al., 1994; Winograd et al., 2004). 
It has been observed that the rate of transport of anion substrate depends on the 
conformational change in the structure of Band III which leads to the transfer of a single 
substrate across the membrane, and the rates of association and dissociation of the 
substrate are much faster than the rate of the conformational change that leads to the 
translocation of the bound anion (Jennigs, 1985; Passow, 1986). It was known that Band 
III proteins undergoes such modifications upon malaria infection (Giribaldi et al, 2001; 
Sherman et al., 2003; Winograd and Sherman, 2004; Winograd et al., 2005). 
  
Recently, the effect of protease on the Band III and NPP activity in infected erythrocytes 
were compared. Because of the different behaviour of Band III and NPP after 
chymotrypsin treatment, the authors concluded that NPPs activity is not only dependent 
on Band III (Baumeister et al., 2006). Although Band III itself may not be the actual 
channel protein mediating the NPP, its conformational change after infection may have 
an important role for the survival of the parasite within erythrocytes. Therefore, in this 
study an experimental strategy was applied to more precisely define the position within 
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1. 7. Objectives 
The aim of this study is to probe the conformational changes in protein structures using 
biotinylation patterns. Surface biotinylation of intact cells followed by mass spectrometry 
is suggested to be a rapid and effective method for identifying putative conformational 
changes in surface proteins following pathogen infection or under varying physiological 
conditions. This approach has great potential for the selective chemical modification and 
analysis of extracellular proteins for the other biological systems. 
To initially establish the experimental system and protocols, two soluble model proteins, 
BSA and CA II were studied to determine if specific, experimentally induced 
conformational changes, result in a reproducible biotinylation pattern of lysine residues. 
Additionally, the membrane topology of the erythrocyte Band III protein was studied. It 
has previously been shown that Band III undergoes a conformational change upon 
infection of the erythrocyte with P. falciparum. To validate our established protocols as a 
method for analysing conformational changes in membrane proteins, our experimental 
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2. Materials and Methods 
 




Analytical scale 2414 Sartorius, Göttingen 
Bench scale 1205 MP Sartorius, Göttingen 
Blotting Apparatus Phase,Lübeck 
Incubator     Heraeus,Hanau 
Electrophoresis chamber Phase 
Film Cassettes    Rego 
Laborfuge III                                         Heraeus,Hanau 
Lab roller Spiromix                              Denley,UK 
Magnetic stirrer                                   Combimag RCH,IKA 
Ultraflex mass spectrometer  MALDI-TOF    Bruker Daltonik,Bremen        
pH-Meter 766                                      Calimatic,Mering 
Power supply   21310                          LKB Biochrom, St.Albans, UK                       
Power supply EPS601                     Amersham Pharmacia Biotech,Sweden 
Speedvac centrifuge                            Eppendorf,Hamburg 
Centrifuge Eppendorf,Hamburg 
Thermomixer 5436                               Eppendorf,Hamburg 
UNO-Thermoblock                               Biometra,Göttingen 
Vortexer REAX 2000                           Sartorius, Göttingen 
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2.1.2. Disposable Materials  
 
Culture flasks                                     Greiner, Frickenhausen                                 
Eppendorf reaction tubes                   Eppendorf,Hamburg 
Falcon tubes                                      Greiner, Frickenhausen                                 
Films New RX NIF,Fuji,Japan 
Glass slides                                       IDL,Nidderau                                                
Micro concentrator                            Millipore Corp, Bedford USA                         
Nitrocellulose          Schleicher & Schuell,Dassel                       
Pipettes     Gilson, France                                               
Pipette tips                                        Greiner, Frickenhausen                                 
Whatman Paper                                Schleicher & Schuell, Dassel                        
Zip Tip gel loading column                Eppendorf,Hamburg 
 
2.1.3. Chemicals and reagents 
 
Acetic acid                                         Roth, Karlsruhe                                       
Acetone Roth, Karlsruhe                                        
Acetonitrile       Roth, Karlsruhe                                        
Ammonium hydrogen carbonate      Sigma, Deisenhofen                                
Ammonium persulfate                       Roth, Karlsruhe                                        
BCIP(5-Bromo-4-chloro-3-indolylphosphat) Biomol, Hamburg                                     
Bovine Serum Albumin Fraction V                       Roth, Karlsruhe                                        
Bovine Carbonicanhydrase II Fluka,NeUlm 
Coomassie Brilliant blue R250         Roth, Karlsruhe                                        
Cyano-4-hydroxycinnamic acid         Bruker Daltonik 
D-Biotin Sigma, Deisenhofen                                 
DTT (1,4-diothio-DL-threitol)              Fluka,NeUlm 
ECL-Reagent                                     Amersham Pharmacia Biotech,Sweden 
EDTA    Merck, Darmstadt                                     
Ethanol   Roth, Karlsruhe                                        
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Formic acid HPLC grade                  Sigma, Deisenhofen                                 
Furosemide Sigma, Deisenhofen                                 
Gentamycin     Gibco, Eggenstein                                    
Giemsa solution                                Merck, Darmstadt                                     
Glycin     Roth, Karlsuhe                                         
Glycerin Roth, Karlsuhe                                         
HEPES   AppliChem, Darmstadt                             
Hydrochloric acid Roth, Karlsruhe                                        
Iodocetamide   Sigma, Deisenhofen                                 
Isopropanol Roth, Karlsruhe                                        
Magnesium Chloride                        Roth, Karlsruhe                                        
Methanol Roth, Karlsruhe                                        
Milk powder                                      Roth, Karlsruhe                                        
Nitroblue Tetrazolium Chloride       Biomol, Hamburg                                     
Oligo R3                                           AppliedBiosystems,USA 
Ponceau S pure                                Serva, Heidelberg                                   
Poros R2                                           AppliedBiosystems,USA 
Potassium Chloride                           Roth, Karlsruhe                                        
RPMI 1640 medium                           PAA,Cölbe 
Sodium Azide                                    Roth, Karlsruhe                                        
Sodium Chloride                                Roth, Karlsruhe                                        
Sodium dihydrogenphosphate           Roth, Karlsruhe                                        
Sodium hydrogencarbonate               Roth, Karlsruhe                                        
Sodium hydrogenphosphate              Roth, Karlsruhe                                        
Sodium hydroxide                              Roth, Karlsruhe                                        
Streptavidin conjugated agarose        Pierce,USA 
Sulfo-NHS-LC-Biotin                           Pierce,USA 
TEMED(N,N,N’,N,Tetramethyethylenediamine) Roth, Karlsruhe                                        
Trifluoroacetic acid (TFA)                   Sigma, Deisenhofen                                 
Tris     Roth,Karlsruhe                                        
Trypsin modified sequence grade       Promega,USA 
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2.1.4. Solutions and buffers 
 
Acrylamide solution: 
30% (w/v) Acrylamide 
0.8% (w/v) Bisacrylamide 
 
AP developing buffer: 
100 mM Tris-HCL, pH 9.5 
100 mM NaCl 
5 mM MgCl2 
 
AP developing solution: 
66 µl NBT(nitro blue tetrazolium)  stock solution                  
33 µl BCIP(5-bromo-4-chloro-3-indolyphosphate)  stock solution 
 
BCIP stock solution: 
5% BCIP in Dimethylformamide                         
 
Colloidal Coomassie staining solution: 
0, 08% Coomassie Brilliant Blue G250 (CBB G250) 





0.124 M Tris                    
0.96 M Glycin 
0.05 % SDS 
 
Giemsa stain:                                     
1% (v/v) Giemsa solution 
9% (v/v) Giemsa buffer 
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Giesma buffer 10x ,pH 6.8:               
130 mM Na2HPO4 
100 mM KH2PO4 
 
NBT stock solution:                         
5% NBT in 70% Dimethylformamide 
 
PBS, pH 7.2:                                      
140 mM NaCl 
6.5 mM KCl 
2.5 mM Na2HPO4 
1.5 mM KH2PO4 
 
Ponceau stain:                                    
0.2% Ponceau S red 
3% Trichloroacetic acid  
 
Protease inhibitor cocktail Stock solution: 
200 µg/ml of each of the inhibitors antipain, 
Chymostatin, Aprotonine, Pepstatin, Trypsin, Leupeptin 
Elastinal and Na-EDTA in PBS.Working solution 1:200 dilution 
 
RPS-Medium:  
450 ml RPMI 1640 Medium                                 
50 ml heat denatured human plasma 
 
SDS-PAGE concentraiting gel pH 6.8: 
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SDS sample buffer stock solution: 
63 mM Tris/HCl 
0.5 M sucrose 
0.01 % Bromophenol blue 
5 mM EDTA 
1 % L-methionine 
 
SDS sample loading buffer:             
200 µl 0.5 M DTT 
200 µl 20% SDS 
600 µl SDS sample buffer stock solution 
 
SDS-PAGE separating gel pH 8.8:  
1.5 M Tris/HCl  
0.4 % SDS 
 
Washing buffer for strepdavidin beads: 
Buffer A: 10 mM Tris-HCl, pH 7.5 
0.2% NP-40 
2 mM EDTA 
150 mM NaCl 
Buffer B : 10 mM Tris-HCl, pH 7.5 
0.2% NP-40 
2 mM EDTA 
500 mM NaCl 
Buffer C:  10 mM Tris-HCl pH 7.5 
 
Western Blot Buffer:                         
48 mM Tris/HCl 
39 mM Glycine 
0.0375% SDS 
20% Methanol 
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2.1.5. Host cells and parasite isolates 
 
Human erythrocytes, blood group A Rh +     University blood bank,Marburg 
Plasmodium falciparum isolate FCBR         Philipps University,Marburg 
 
2.1.6. Antibodies and working concentrations 
 
Mouse anti Band III                                Sigma Aldrich,Dilution1:2000                        
Rabbit anti Glycophorin Sigma Aldrich,Dilution1:2000                        
Rabbit anti Spectrin Sigma Aldrich,Dilution1:2000                        
Goat anti rabbit, Alkaline Phosphates (AP)   DAKO Glostrup,Dilution1:2000                      
Goat anti rabbit, Horse radish peroxidase 
(HPR)           
DAKO Glostrup,Dilution1:2000                      
Rabbit anti mouse, Alkaline Phosphatase 
(AP)                  
DAKO Glostrup,Dilution1:2000                      
Rabbit anti mouse, Horse radish 
peroxidase (HPR)           
DAKO Glostrup,Dilution1:2000                      
Horseradish Peroxidase (SAV-HRP) 
Streptavidin avidin   
Pharmingen,USA,Dilution 1:10,000 
alkaline Phosphatase (SAV-AP) 





BiotoolsTM Bruker Daltonic,Bremen 
FlexAnalysisTM Bruker Daltonic,Bremen 
FlexAcontrolTM Bruker Daltonic,Bremen 
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2.2.1. Parasite Cultures 
 
Parasites, P. falciparum FCBR were cultured in RPMI 1640 medium supplemented with 
10% heat in-activated (56°C, 30 min) human plasma and erythrocytes of blood A+ group 
(Marburg Blood Bank) using standard procedures (Trager and Jensen, 1976). 
Trophozoite-infected erythrocytes were enriched to a parasitaemia of > 90% by gel 
floatation (Pasvol et al., 1978).  
 
2.2.2. Biotin labelling of bovine serum albumin and carbonic anhydrase II 
  
Fatty acid free bovine serum albumin (BSA) was dissolved in phosphate buffered saline 
(PBS) to a final concentration of 10 mg/ml. For the analysis of the biotinylation pattern   
of BSA, 1ml of the solution containing 1.449 x 10-4 moles BSA was biotinylated with 1, 
20, 40 and 60 molar equivalents of sulfo-LC-biotin for 30 min at 4°C.  The reaction was 
stopped by adding glycine to final concentration of 10 mM. The unreacted biotin 
derivative was removed from the sample by centrifugation at 3,000 x g using a 
microconcentrator (Millipore Corp.) with a size exclusion of 5 kDa, this step was 
repeated twice after dilution with PBS before determining the protein concentration using 
the BCA system (Pierce). For bovine carbonic anhydrase II (CA II) 1.15 x 10 –4 moles 
were biotinylated using a 40 fold molar excess of biotin derivative and processed as 
described for BSA. 
For the analysis of artificially induced conformational changes, BSA and CA II were 
prepared as described above and subjected to elevated temperatures of 56°C or 80°C 
for 30 minutes before cooling and biotinylating with a 1:40 fold molar excess of the biotin 
derivative. To study BSA protein after thermal and chemical denaturation, BSA was 
subjected to an elevated temperature of 80°C for 30 min in the presence of 10 mM 
dithiothreitol (DTT), before cooling and biotinylating with the 40 fold molar excess of the 
biotin derivative or alternatively BSA was exposed to the temperature above 80°C, 
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reduced by 10 mM DTT and alkylated with 50 mM iodoacetamide for 45 min at room 
temperature in darkness before biotinylation as described. 
 
2.2.3. Biotinylation of erythrocyte membrane protein Band III 
 
Biotinylation was performed on non-infected human erythrocytes and in Plasmodium 
falciparum-infected human erythrocytes. 2 x 108 infected or non-infected erythrocytes 
were washed with PBS pH 7.6 and incubated in the same buffer containing different 
concentrations of the biotin derivative (2mg ml -1, 1mg ml-1, 0.5 mg ml-1) for 1 h at 4°C in 
the presence of 100 µM furosemide. A negative control was included and the cells in 
both groups incubated under the same conditions but without biotin. Cells were 
sedimented by centrifugation at 1,300 x g at 4°C for 5 min. To block and remove 
unreacted  biotin derivative molecules, cells were washed three times in PBS pH 7.6 
containing 100 mM glycine and finally in PBS.  Soluble proteins were released after 
resuspending the cells in distilled water supplemented with a protease inhibitor cocktail 
to inhibit proteolysis and subjected to three cycles of freezing and thawing. A membrane 
fraction and a soluble fraction were prepared by centrifugation at 18,000 x g for 20 min. 
The membrane fraction was solubilized using SDS-PAGE sample buffer and separated 
in a 7.5% SDS-PAGE. 
 
2.2.4. Affinity purification of biotinylated peptides  
 
For each experiment 72 µl of streptavidin sepharose beads were washed extensively 
with a buffer containing 1% NP-40 (v/v) in PBS before mixing with 100 µg of BSA or CA 
II biotinylated with different molar concentrations of biotin and incubating overnight at 
4°C. The unbound non-biotinylated protein fraction was obtained as a supernatant after 
centrifugation at 10,000 x g for 10 min. The pelleted beads containing bound biotinylated 
protein was washed three times in buffers A, B and finally in buffer C. The bound protein 
was eluted after boiling in 500µl of denaturing SDS-PAGE sample buffer and separated 
in a 10% gel. 
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2.2.5. Gel Electrophoresis (Laemmli, 1970) 
 
For 1D SDS-PAGE protein samples were dissolved in SDS-sample buffer and separated 
on 7, 5% or 10% gels under reducing conditions. The protein bands were then visualized 
by Coomassie staining. 
 
2.2.6. Western Blot Analysis (Towbin et al., 1979) 
 
Proteins separated by SDS-PAGE were transferred to nitrocellulose membranes using 
semi dry-blotting. To detect biotin labeled proteins, the membranes were blocked with 
3% BSA in PBS, pH 7.4, for 1 h at room temperature before incubation for 20 min with 
alkaline phosphatase-conjugated streptavidin (1:10,000/ 3% BSA in PBS, pH 7.4). The 
membranes were washed with 10 mM Tris-HCl, pH 7.4, 150 mM NaCl for 5 min and 
then in the same buffer containing 0.05 % Triton-X 100 for another 5 min.The biotin 
labeled proteins were visualized after staining with NBT and BCIP.The same 
membranes were then incubated with specific marker proteins at a dilution of 1:500 at 4° 
C overnight. Specific marker proteins were detected after incubation with horseradish 
peroxidase-conjugated anti-rabbit IgG (Dako) for 1h at room temperature and 
development of the filters using the ECL system (Amersham Biosciences) following the 
suppliers recommendation. 
 
2.2.7. Sample preparation for mass spectrometry 
 
For the analysis of intact protein,the biotinylated and non-biotinylated protein (BSA) in 
final concentration of 250 µg/ml was dissolved in ammonium bicarbonate 100 mM .The 
protein solution was purified and concentrated using ZipTipsTM columns made from the 
reverse chromatography resins Poros R2 and Oligo R3 and eluted from the ZipTipsTM 
with 2 µl of 33% (v/v) acetonitrile/ 0.1 % trifluoroacetic acid solution saturated with 
sinapinic acid directly onto a MALDI sample plate and air dried before analysis by the 
mass spectrometer in linear TOF mode.  
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For the analysis of peptides, protein bands were excised from polyacrylamide gels and 
subjected to in-gel trypsin digestion before mass spectrometric analysis (Helman et al., 
1995). Briefly, the excised spots were washed with 50% v/v acetonitrile (ACN) in 200 
mM ammonium bicarbonate, the destained protein was in-gel reduced with 10 mM 
dithiothreitol (DTT) in 100 mM ammonium bicarbonate for 1 h at 56°C and alkylated with 
50 mM iodoacetamide in the same buffer for 45 min at room temperature in darkness. 
The gel pieces were washed with 100 mM ammonium bicarbonate, dehydrated in ACN, 
and dried. The gels were re-swollen in 15 µl of 40 mM ammonium bicarbonate 
containing 20 µg ml-1 sequencing grade trypsin (Promega) for 45 min at 4° C. Excess 
protease containing solution was discarded and the gel pieces were incubated  at 37 °C 
for 18 hours.  
To extract the peptides, 15 µl of a diffusion solution (10% ACN, 1% trifluoro-acetic acid 
(TFA)) were added and the samples sonicated for 45 min at 37 °C. The soluble portion 
of the sample was evaporated to dryness. For mass spectrometry measurements the 
samples were redissolved in 15 µl of 0.1% v/v TFA, 5 % v/v ACN in water. The peptides 
were purified and concentrated using ZipTipsTM columns made from the reverse 
chromatography resins Poros R2 and Oligo R3. The bound peptides were washed with a 
solution of 0.5% formic acid and eluted from the ZipTipsTM with 2 µl of 33% (v/v) 
acetonitrile/ 0.1 % trifluoroacetic acid solution saturated with a-cyano-4-hydroxycinnamic 
acid directly onto a MALDI sample plate and air dried before analysis in the mass 
spectrometer.  
Alternatively, for the affinity enrichment of biotinylated tryptic peptides, SDS-PAGE 
separated proteins were transferred to nitrocellulose membrane and visualized by 
Ponceau staining. The stained membrane was cut into 2 x 2 mm square pieces and 
thoroughly destained with water, treated with 10 mM dithiothreitol in 100 mM ammonium 
bicarbonate for 1 h at 56°C and alkylated with 50 mM iodoacetamide in the same buffer 
for 45 min at room temperature in darkness. The nitrocellulose pieces were washed with 
100 mM ammonium bicarbonate and dried. The membranes were incubated in a 
minimal volume of 40 mM ammonium bicarbonate containing 20 µg ml-1 sequencing 
grade trypsin (Promega) and incubated at 37°C for 18 hours. The tryptic peptides were 
extracted from the membrane pieces using 20% ACN in 1% TFA twice, with sonication 
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at 37°C for 45 min. The eluted peptides were resuspended in 500 µl of 100 mM 
ammonium bicarbonate and incubated overnight with 72 µl of washed streptavidin 
sepharose beads to affinity purify the biotinylated peptides. The unbound, non-
biotinylated peptide fraction was obtained as a supernatant after centrifugation at 10,000 
x g for 10 min. This fraction was evaporated to dryness and resuspended in 0.1% TFA 
before processing for MS. The sepharose beads containing bound biotinylated peptides 
were washed three times in 100 mM ammonium bicarbonate, 1% octylglucoside. The 
bound peptides were eluted with 70% ACN, 5% TFA, and 1 mM D-biotin in 100 mM 
ammonium bicarbonate at room temperature for 2 h. The solution was evaporated to 
dryness and resuspended in 0.1% TFA before processing for MS. 
 
 2.2.8. Mass spectrometry analysis and protein identification 
 
Mass spectrometry was performed using a Bruker Daltonics UltraflexTM mass 
spectrometer equipped with a nitrogen laser (laser 337 nm, 3nspulse width and 50 Hz 
repetition rate) and  Panoramic mass range focusing (PAN™) technology and High-
Precision Calibration (HPC™) for high mass accuracy. For the analysis of intact protein, 
mass spectra were acquired after an external calibration using reference protein 
standards; trypsinogen, protein A, Albumin-Bovine, Protein A 2+ and Albumin-Bovine 2+ 
(Protein calibration standard II, Bruker Daltonics). Mass spectra were acquired in the 
linear positive mode with a pulsed extraction using approximately 100 laser shots and 
the masses assigned and processed using BiotoolsTM and FlexAnalysisTM software 
(Bruker Daltonics). For the tryptic digests peptide mass fingerprint spectra were acquired 
in the reflectron positive mode with a pulsed extraction using an average of 100 laser 
shots. The spectra were acquired after an external calibration using reference peptides 
(Peptide mixture II, Bruker Daltonics). The spectra were further internally calibrated 
using trypsin autolysis peaks (842.5100, 2211.1046 Da). Monoisotopic masses were 
assigned and processed using BiotoolsTM and FlexAnalysisTM software before 
submission to the Mascot program (www.matrixscience.com) for searches against the 
non-redundant NCBI database. The following variable modifications were used in the 
searches; methionine oxidation, lysine sulfo NHS-LC-biotin labelled, Pyro-glu from E at 
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the N-terminus, Pyro-glu from Q and a fixed cysteine carbamidomethylation 
modification. To analyze the effect of missed proteolytic cleavage of peptides on the 
identification of the proteins and biotinylated lysine residues, the searches were done 
allowing complete cleavage (0 miscleavage sites) and allowing 1 or 2 miscleavage sites. 
A mass accuracy of 50 ppm or better was used in all the identifications. 
MS-MS analysis was done using the LIFTTM mode to provide i-, a-, b- and y-ions. The 
masses of the fragmented ions were submitted to the Mascot program for database 
searching using the following parameters; peptide mass tolerance of 100 ppm, MS-MS 
tolerance of 0.7 Da and 2 missed cleavage sites. The variable and fixed modifications of 




















As noted in the goals section of this thesis, the aim of this study was to use biotinylation 
patterns in order to probe conformational changes in protein structures. To establish the 
system, BSA was used as a model protein, as the structure of this protein has been 
determined using various methods, and it is readily and cheaply available in the 
laboratory.  
  
3.1. Biotinylation pattern of BSA is saturable. 
 
In order to probe conformational changes in proteins using BSA, it was necessary to 
establish whether the biotinylation of our model protein BSA is saturable, as this is 
required to achieve consistent results.  
The biotinylation reaction that occurs between the active ester group of sulfo-NHS-LC 
biotin derivatives and the primary amines of proteins and/or the epsilon amino group of 
lysine residues with the formation of an amide bond resulting in an increase in mass by 
339.1611 Da for each lysine residues in polypeptide (Figure7). 
    
 
Figure 7. Biotinylation with sulfo-NHS-LC-Biotin increases the mass of peptides by a specific 
value. Using peptide mass finger printing after mass spectrometry it is possible to identify modified lysine 
residues in peptides. Modified peptides show a mass shift of 339.1611 Da compared to the non-






Since BSA has 60 lysine residues, it is to be expected that under optimal conditions all 
these residues can be biotinylated. This however assumes that all lysine residues are 
accessible to the biotin moiety, which is unlikely considering the tertiary protein 
structure. Nevertheless, if all the 60 lysine residues are biotinylated the calculated mass 
shift of the protein would be 20.34 kDa. To investigate the effect of biotinylation of BSA 
on the electrophoretic mobility and mass alteration of protein, the intact protein was 
biotinylated with an increasing molar ratio concentration of sulfo-NHS-LC-biotin 
derivatives. After the removal of excess unreacted biotin by size exclusion 
centrifugation, the biotinylated and non-biotinylated control proteins were subjected to 
1D gel electrophoresis and in a parallel experiment the intact protein was directly 
analyzed by linear TOF by mass spectrometry to determine the number of lysine 
residues that had been biotinylated. An analysis of biotinylated protein by SDS-PAGE 
confirmed the increase in molecular mass of Coomassie stainable protein, which was 
verified by biotin detection with streptavidin (SAV). As shown in figure 8, an increase in 
the concentration of the biotinylating reagent leads to an increase in the mass of the 
protein up to a maximum of 40 fold molar excess of biotin (Figure 8, lane 5). Further 
increase in concentration to 60 fold molar excess does not results in any significant 




Figure 8. Analysis of the mass of BSA after biotinylation using increasing concentrations of sulfo-
NHS-LC-Biotin. BSA was biotinylated with sulfo-NHS-LC biotin at different molar ratios and analyzed by 
SDS-PAGE and Coomassie staining or by reaction with alkaline phosphatase-conjugated SAV on 






The MS-TOF spectrometry in linear mode also showed that the increase in mass of 
protein is in an almost linear correlation with the molar excess of biotin derivatives up to 
a 40 fold molar excess of derivative (Figure 9 and Table 2). 
 
Mole ratio 
Sulfo-NHS-LC-biotin : BSA 
Mass of BSA by MS 
(Da) 
Number of incorporated 
biotinylated residues 
(Predicted from mass shift) 
0 66,525.3 none 
1 66,598.0 Not detectable 
10 68,269.0 5 
20 69,853.9 10 
40 72,271.4 17 
60 72,599.5 18 
 
 
Table 2. Effect of the increase in the molar ratio of sulfo-NHS-LC-biotin to BSA on the mass of 
BSA. BSA was biotinylated with increasing mole ratio concentration of sulfo-NHS-LC-biotin derivatives 
and the biotinylated protein was subjected to be analyzed by linear mode time of flight mass spectrometry. 




Figure 9. Effect of the increase in the concentration of sulfo-NHS-LC-biotin on the biotinylation and 
mass of BSA. BSA was biotinylated with increasing mole ratio concentration of sulfo-NHS-LC-biotin 






3.2. Biotinylated lysine residues in BSA are uniformly distributed in the protein  
 
In addition to the analysis of the mass of the intact protein, the biotinylation of BSA was 
analyzed by peptide mass finger printing (PMF) to investigate whether biotinylation 
occurred randomly or whether specific lysine residues were preferentially biotinylated. 
BSA was biotinylated with 1,10,20,40 and 60 fold molar excess of sulfo-NHS-LC-biotin. 
The biotinylated and non-biotinylated BSA was subjected to 1D gel electrophoresis. The 
SDS-PAGE separated proteins were digested with trypsin and the eluted peptides 
subjected to mass spectrometry before identification by peptide mass fingerprinting. As 
shown in table 3, the number of biotinylated peptides (lysine residues) increased with 
the increase in the concentration of the biotin derivative.  Beyond 40 fold molar excess 
of the derivative no new biotinylated lysine residues are identified. As in the analysis of 
the intact protein, there is a correlation between the numbers of the modified lysine 
residues identified by MS and the predicted numbers after MS of the intact protein in the 
linear mode. More importantly, when biotin concentrations below the point of maximal 
incorporation were used, labelling of lysine residues did not occur randomly but at 
specific sites. Lysine residues which were biotinylated at lower concentrations of the 
biotin derivative were also biotinylated when higher concentrations were used. All lysine 
residues which were biotinylated were detected in 5 out of 5 analyses. These findings 
indicate a concentration dependent, preferential accessibility of individual residues. In 
addition, the biotinylation process was highly specific and reproducible between 
experiments suggesting that the labelling is dependent on the conformation of the 
protein. Since biotinylation of BSA is saturated beyond 40 fold molar excess of biotin 











Lysine Molar ratio Sulfo-NHS-LC-Biotin / BSA 
(K) φ 1 10 20 40 60 
K 36    + + + 
K 100     + + 
K 156    + + + 
K 160    + + + 
K 204    + + + 
K 211   + + + + 
K 228     + + 
K 235  + + + + + 
K 245     + + 
K 266     + + 
K 374     + + 
K 401   + + + + 
K 412     + + 
K 420     + + 
K 455  + + + + + 
K 463     + + 
K 498     + + 
K 559     + + 
Total 0 2 4 8 18 18 
 
Table 3. Biotinylation of individual lysine residues follows a concentration dependent specific 
order. BSA was biotinylated with 1, 10, 20, 40 and 60 fold molar excess of sulfo-NHS-LC-biotin. Tryptic 
peptides were analyzed by tandem mass spectrometry to identify biotinylated lysine residues. All lysine 




3.3. Not all lysine residues of BSA can be detected by mass spectrometry 
 
As shown in the previous section, addition of a biotin derivative leads to a circa. 339 Da 
shift in lysine-containing peptides derived from the BSA protein. In this study one portion 
of BSA was subjected to be biotinylated using 40 fold higher molar ratio of biotin 
derivative at room temperature. The other portion of BSA was not biotinylated. After 
separation by gel electrophoresis, the Coomassie stained protein bands were cut, 
digested with trypsin and subjected to mass spectrometry in the reflectron mode. The 
obtained mass list was used to search against database. Protein was identified from 
peptide mass fingerprints using the Mascot search program with the MSDB database. 




methionine and carbamidomethylation of a cysteine residue were considered for 
modifications. Both protein samples were identified as BSA with more than 56% 
sequence coverage. The sequence coverage was calculated by using all amino acids in 
the detected peptides which could be identified in the primary sequence of the protein. 
The obtained sequence coverage of BSA is shown in figure 10. Note that although the 
sequence coverage is similar, this coverage is composed of peptides that differ between 




Figure 10. Comparison of the detected sequence coverage in biotinylated and non-biotinylated 







MS analysis of the non-biotinylated BSA detected 27 different peptides, ranging in mass 
from 689.41 to 2458.21 Da. Out of the total 60 lysine residues in the BSA amino acid 
sequence, 26 lysine residues were identified. The mass spectra of peptides from 
biotinylated BSA shows more peaks than from non-biotinylated BSA. In the modified 
BSA, 36 different peptides were identified with masses ranging from 599.33 to 2868.51 
Da. Among the identified peptides, 34 lysine residues were found of which 18 lysines 










K 2 - - K 309 + + 
K 28 - - K 318 - -- 
K 36 + + K 336 + + 
K 44 + - K 340 + + 
K 65 - - K 346 - - 
K 75 + + K 374 - + 
K 88 - - K 386 - + 
K 100 + + K 399 + - 
K 117 - + K 401 - + 
K 130 + - K 402 + + 
K 138 + + K 412 + + 
K 140 + - K 420 - + 
K 151 + - K 437 + + 
K 155 - - K 455 - + 
K 156 - + K 463 - + 
K 160 - + K 489 - - 
K 183 + + K 495 - - 
K 197 + - K 498 - + 
K 204 - + K 523 + + 
K 211 - + K 528 - - 
K 228 - + K 544 + + 
K 235 - + K 547 - - 
K 245 + + K 548 - - 
K 248 - + K 557 - - 
K 256 - - K 559 - + 
K 263 - - K 561 - - 
K 266 - + K 568 - - 
K 285 + - K 580 + + 
K 297 + - K 587 + - 
K 299 - + K 597 + - 
K 304 + + total 26 34 
 
Table 4. List of detected lysine residues in biotinylated and non-biotinylated BSA. One portion of 
BSA was biotinylated using 40 fold molar excess of sulfo-NHS-LC-biotin. The other portion of BSA was 
not biotinylated. Biotinylated and non-biotinylated samples were separated by SDS-PAGE and processed 




As shown in Table 4, 16 lysine residues were found in both biotinylated and non-
biotinylated samples. Ten Lysine residues were only detected in non-biotinylated BSA 
where 18 lysine residues were only identified through the modified peptides after 
biotinylation of BSA with 40 fold molar biotin derivatives. 14 lysine residues were 
detected neither in biotinylated nor in non-biotinylated BSA. Furthermore four lysine 
residues were detected in both modified and non-modified versions in biotinylated BSA.  
To predict the tryptic BSA peptides and to determine the distribution of lysine residues in 
BSA amino acid sequences, a theoretical digestion of BSA protein was done by 
ExPASY (Expert Protein Analysis System) proteomic server (www.expasy.org) using 
trypsin as a protease and setting the input parameters to include oxidation of 
methionine, carbamidomethylation of cysteine and maximum one missed cleavage site. 
The in silico trypsin digestion of BSA generated 180 theoretical peptides with their 
corresponding masses between 500.246 to 3579.85 Da. More than half of these 
peptides contain one or two lysine residues. 11 peptides among the theoretical digested 
peptides in BSA sequences have a mass of less than 600 Da. These low molecular 
weight peptides could not be detected, probably because their location on the spectra 
overlapped with the matrix clusters peaks. Two of these lysine-containing peptides 
(K156 and K559) were later identified from the biotinylated sample as biotinylated 
peptides, which increased their mass. Detection of long polypeptides with mass larger 
than 2000 Da in both samples is also limited because of their hydrophobic character. 
These high molecular weight peptides contain cysteine or methionine residues. 
Hydrophobic peptides can be lost during sample preparation because of adsorption to 
plastic surfaces of pipette tips and cups. In addition, in MALDI mass spectra as m/z of 
peptide increases, resolution and mass accuracy progressively decrease. This causes 
unmatched masses which are excluded from the mass list for the protein identification.  
 
3.4. The modified lysine residues are identified by MS and MS/MS analysis 
 
Comparison of the MS spectra from biotinylated and non-biotinylated BSA clearly 
reveals differences and indicates, as expected, some peaks which are only present in 




in comparing of sections from two mass spectra, three new peaks with m/z of 1156.633, 
1329.692 and 1340.712 with significant intensities were observed in the biotinylated 
sample through all experiments. Further analysis of each of these peptides after 





Figure 11. Comparison of biotinylated and non-biotinylated BSA. One fraction of BSA was 
biotinylated with 40-fold higher mole ratio of biotin derivative. The other fraction was non-biotinylated. The 
same aliquot of two fractions was separated by 1D gel electrophoresis and later analyzed by mass 
spectrometry. The upper spectrum is from the biotinylated protein and the other one from non-biotinylated 
BSA. The marked peaks show the biotinylated peptides. 
 
Analysis of the peptide with m/z 1329.694 by tandem mass spectrometry resulted in the 
fragmentation of the peptide into its constituent amino acids. MS/MS analysis 
determined the sequence of the peptide (EKVLTSSAR) (Figure 12). Comparison of the 
observed mass (1329.694) and theoretical mass (990.5472) of this peptide showed a 




figure 12, the biotin tag is detectable in spectra with a mass of 340.157. In addition the 








Figure 12. MS/MS spectra of peptide 1329.694 which was detected in the biotinylated BSA. The 
sequence of peptide (EKVLTSSAR) has one missed cleavage site and the spectrum contains the biotin 
tag peak in mass 340.157 Da. 
 
 
3.5. Biotinylated peptides can be effectively affinity purified using streptavidin 
sepharose beads 
 
In order to isolate only peptides derived from biotinylated BSA molecules, biotinylated 
intact protein or biotinylated peptides were affinity purified by streptavidin sepharose 





3.5.1. Affinity purification of intact biotinylated BSA 
  
In the first experiment, biotinylated BSA was isolated by streptavidin sepharose beads, 
tryptically in gel digested and the resulting peptides analysed by mass spectrometry 
(Figure 13, left side).  
 
 
Figure 13. Schematic representation of the experimental methodology for the affinity purification 
of biotinylated intact BSA or biotinylated BSA peptides using streptavidin beads. BSA was 
biotinylated with 40-fold higher mole ratio of sulfo-NHS-LC-biotn and purified by streptavidin beads (SAV) 
either as an intact biotinylated protein or as biotinylated peptides, the purified samples were eluted and 
analyzed by mass spectrometry.  
 
As shown in figure 14, at a molar ratio of 1:1 most of the BSA is not biotin labelled and it 
is not bound by Streptavidin beads. At biotin molar ratios 1:20 and 1:40 all the BSA is 
biotin labelled and it binds to the SAV beads. As expected there is no significant 
increase in the mass of BSA after labelling with Sulfo NHS-LC- biotin at molar ratios 
greater than 1:40 (Figure 14, Lane 11 and 12). A substantial amount of biotinylated BSA 




densitometric analysis indicated that only boiling of the beads in the denaturing sample 
buffer yielded a partial recovery of biotinylated protein from streptavidin Sepharose (65% 




Figure 14. Comparison of bound and unbound fraction of biotinylated BSA. 100 µg of biotinylated 
BSA were incubated with 72 µl of Streptavidin beads, and 10µg equivalents of the unbound and bound 
fractions were analyzed by SDS-PAGE and western blot.  
 
 
3.5.2. Affinity purification of biotinylated BSA peptides 
 
In a parallel, complementary approach to 3.5.1, biotinylated BSA which was separated 
by 1D gel electrophoresis and transferred to nitrocellulose membrane, subjected to 
tryptic digestion and the resulting peptides were then purified by streptavidin sepharose 
beads as described above (Figure 13, right side). The comparison of the spectra from 
starting, bound and unbound fractions is shown in figure 15. Data base searching of 
generated peptides in bound fraction identified the protein as BSA. In the bound fraction, 
23 BSA specific peptides were detected by MS. Out of all reported peptides, 95% were 
biotinylated (Table 4) which indicates the efficient affinity purification of biotinylated 
peptides from the streptavidin beads. Only 2 peptides containing lysine residues K285 
and K386 were observed in the bound fraction which were non-biotinylated and could 
possibly be binding non-specifically to the streptavidin sepharose beads.These non-




biotinylated peptides the sequences of non-biotinylated peptides [(ADLAK) and 
(EYEATLEECCAK)] have no missed cleavage site. The MS analysis of the unbound 
fraction identified only four peptides and they all are not biotinylated. Two unmodified 
lysine residues (K75 and K374) were detected in this fraction.  
 
 
Figure 15. Comparison of generated peptides from starting, bound and unbound fractions of 
biotinylated BSA. Biotinylated BSA was separated by SDS-PAGE and transferred to nitrocellulose filters. 
The band was trypsinized and the generated peptides were affinity purified using streptavidin sepharose 
beads. The starting, bound and unbound fractions were subjected to mass spectrometry using the 





3.6. Biotinylated lysine residues are resistant to trypsin cleavage 
 
The identification of proteins by peptide mass fingerprinting (PMF) is dependent on the 
generation of peptides by protease treatment, determination of their masses by mass 
spectrometry and comparison of these masses to theoretical masses in databases. 
Trypsin, the most commonly used protease specifically cleaves peptides at the carboxyl 
termini of the basic amino acid residues arginine and lysine. This reaction is inhibited by 
the presence of a proline residue at the C-terminus adjacent to these two amino acids. 
The inhibition of trypsin cleavage generates partials i.e. peptides with missed cleavage 
sites. Since biotinylation occurs at the protonated epsilon amino group of the lysine 
residue, the effect of biotinylation on the recognition and cleavage of lysine residues was 
analyzed. BSA was biotinylated with 40 molar excess of the biotin derivative and 
processed as described above. Nitrocellulose bound BSA was subjected to tryptic 
cleavage in an excess of the protease. The generated peptides were eluted and the 
biotinylated peptides were affinity purified on streptavidin beads and analyzed by MS 
before submitting the masses for searching using the MASCOT search machine.In this 
analysis, setting the missed cleavage site to 0 in the searches did not identify the 
sample as BSA, clearly indicating that there were several missed cleavage sites after 
biotinylation. However increasing the missed cleavage sites to 1 in the searches, 
identified BSA with a high Mascot score and 56% sequence coverage. MS analysis 
showed that all 21 identified biotinylated BSA peptides, contained a lysine missed 
cleavage site while the 2 non-biotinylated peptides did not have a missed cleavage site 
(Table 5).The results showed that the biotinylation of a lysine residue prevents cleavage 
by trypsin at that site in the lysine-containing peptide.Increasing the number of missed 










amino acids m/z Missed cleavage sites Amino acid sequence 
35 - 44 1588.78 1 FK*DLGEEHFK 
89 - 105 2285.17 1 SLHTLFGDELCK*VASLR 
156 - 160 1004.54 1 K*FWGK 
157 - 167 1784.91 1 FWGK*YLYEIAR 
198 - 209 1727.90 1 GACLLPK*IETMR 
210 - 218 1329.72 1 EK*VLTSSAR 
223 - 232 1534.73 1 CASIQK*FGER 
233 - 241 1340.76 1 ALK*AWSVAR 
242 - 248 1186.67 1 LSQK*FPK 
264 - 280 2453.09 1 VHK*ECCHGDLLECADDR 
281 – 285 517.39 0 ADLAK 
372 - 386 2154.00 1 LAK*EYEATLEECCAK 
375 - 386 1502.67 0 EYEATLEECCAK 
400 - 420 3274.72 2 LK*HLVDEPQNLIK*QNCDQFEK
413 - 433 2868.47 1 QNCDQFEK*LGEYGFQNALIVR 
452 - 459 1156.66 1 SLGK*VGTR 
460 - 468 1505.66 1 CCTK*PESER 
496 - 507 1805.89 1 VTK*CCTESLVNR 
558 - 568 1647.87 1 HK*PKATEEQLK 
 
 
Table 5. Biotinylated lysine residues are resistant to trypsin. BSA was biotinylated with 40 molar 
excess of the biotin derivative and processed as described in materials and methods. The protein was 
digested and analyzed by MS before submitting the masses for searching using the MASCOT search 
machine to identify the peptides. K* indicates biotinylated lysine residue, with a missed cleavage site.     
 
 
3.7. Elevated temperatures expose novel lysine residues in the biotinylation 
pattern of BSA 
 
Since the biotinylation pattern of BSA is highly reproducible and obviously depends on 
the accessibility of individual lysine residues in the protein structure, it was examined 
whether treatments that result in conformational changes of the protein affect 
biotinylation patterns. BSA molecule has a heart shaped structure made up of three 
homologous domains which are divided into nine loops by 17 disulphide bonds. Serum 
albumin when heat-treated, undergoes two different structural stages. The first stage is 
reversible whilst the second stage is irreversible but does not necessarily result in a 
complete destruction of the ordered protein structure. Heating up to 65°C can be 
regarded as the first stage, with subsequent heating above that as the second stage. 
Therefore heating above 65°C results in thermal denaturation and possibly 




exposing the protein to different temperatures. BSA was biotinylated at room 
temperature with a 40 fold molar excess of sulfo-NHS-LC-biotin or subjected to elevated 
temperatures of 56°C and 80°C for 30 min before cooling and biotinylating with the 40 
fold molar excess of the biotin derivative as described above. The proteins were 
separated by SDS-PAGE. As shown in figure 16, heat treatment of BSA to the 
temperature of 56°C (Lane 3) and 80°C (Lane 4) before biotinylation does not results in 
the significant difference in the pattern of the protein electrophoresis which suggested 
that either the biotinylation pattern of BSA after exposure to the different temperature 




Figure 16. Comparison of the biotinylation pattern of BSA after exposure to different temperatures. 
BSA was biotinylated with sulfo-NHS-LC biotin at room temperature (RT) or after exposure to 56°C and 
80°C before cooling and biotinylation and analyzed by SDS-PAGE and Coomassie staining. 
 
To confirm any changes in the biotinylation pattern of BSA after temperature treatment, 
the Coomassie stained bands were excised and analyzed as described above by PMF 
to identify biotinylated peptides. For BSA treated at 56°C, the MS analysis revealed 
identical biotinylated peptides as detected at room temperature but exposure of BSA to 
a temperature above 80°C prior to biotinylation results in the biotinylation of two new 
lysine residues which are not biotinylated at room temperature or after exposure to 56°C 
(Table 5). The comparison of the spectra of the biotinylated BSA with and without the 
temperature treatment indicated two extra peaks with m/z 1979.113 (K437) and 
2810.104 (K523) in the biotinylated spectra which were detected only in the biotinylated 







Figure 17. Sections of the MALDI mass spectra for BSA biotinylated at RT and after exposure to an 
elevated temperature of 80°C. In a, the arrow indicates the peak cluster corresponding to the 
biotinylated peptide. In a K437 is biotinylated only after BSA is exposed to 80°C.In b, the arrow indicates 






These observations were confirmed by MS and tandem mass spectrometry. The peak 
with m/z 1979.113 corresponds to the peptide 437-451 of BSA with sequence 
(KVPQVSTPTLVEVSR) in which K437 is biotinylated. The MS/MS spectra and 
generated fragments ions were shown in figure 18. In contrast to the biotinylated lysine 
residues which were previously detected, the 1979.113 peptide has no missed cleavage 
site. This can be explained, as the biotinylated lysine is located at the N-terminus of the 
peptide and the peptide was generated after cleavage to the C-terminus of the adjacent 
arginine residue. The peak corresponding to the unmodified form of the peptide with m/z 





Figure 18.  MS/MS analysis of peptide 1979.09 that is only biotinylated after exposure to a 




Figure 19 shows the MS/MS spectra of the peptide with m/z 2810.100 corresponding to 
the amino acid sequence 508-528 of BSA. The MS analysis confirmed the sequence 
(RPCFCSALTPDETYVPKAFDEK) with K523 biotinylated. As described before, 
biotinylated peptides contained a missed cleaved lysine residue. Unmodified lysine K523 
was detected in the shorter peptide with the sequence RPCFSALTPDETYVPK in both 





Figure 19.  MS/MS analysis of peptide 2810.253. The peptide is only biotinylated after exposure to a 





3.8. Reduction has no effect on the biotinylation pattern of BSA  
 
BSA has a total of 35 cysteine residues which form 17 disulphide bonds that join the 9 
loops forming the 3 domains of the protein. The primary structure of BSA   possesses a 
single sulfhydryl (Cys-34) group. The disulphide bonds are located almost between 
helical segments in the BSA sequence as following position:  
(1) 77-86; (2) 99-115; (3) 114-125; (4) 147-192; (5) 191-200; (6) 223-269; (7) 268-276; 
(8) 288-302; (9) 301-312; (10) 339-384; (11) 383-392; (12) 415-461; (13) 460-471; (14) 
484-500; (15) 499-510; (16) 537-582; (17) 581-590. 
Among the total 60 lysine residues in BSA sequence, 31 lysines residues are located 
in/around the regions which are involved in forming disulphide bonds. Out of these, 15 
lysine residues were biotinylated in the preceeding experiments where BSA was 
biotinylated either at room temperature or after heating to different temperatures. 
After showing that an increase in temperature results in the biotinylation of new lysine 
residues, it was necessary to confirm whether other treatments that result in the 
unfolding of the protein would lead to the biotinylation of more lysine residues. To 
achieve this, BSA was subjected to an elevated temperature of 80°C for 30 min in the 
presence of DTT before cooling and biotinylating with the 40 fold molar excess of the 
biotin derivative or alternatively BSA was exposed to temperatures above 80°C, reduced 
by DTT and alkylated with iodoacetamide for 45 min at room temperature in darkness 
before biotinylation as described. The protein was separated by SDS-PAGE and the 
protein bands were processed and analyzed as described above by PMF to identify 
biotinylated peptides. MS analysis showed the identical biotinylated peptides as 
detected before in the biotinylated BSA after treatment at 80°C. No new lysine residues 
could be biotinylated after reduction of BSA using DTT (Table 6).  
This would imply that the either the new lysine residues are not exposed by this 
treatment or they simply cannot be biotinylated due to other factors e.g. steric hindrance. 
These findings are consistent with previous data which indicated that the majority of 
BSA disulphide bonds are not accessible to the solvent and they are protected from 




bridges is involved in the maintenance of the BSA structure (Carter and HO, 1994; Pico 
et al., 1997; Restani et al, 1988). 
 
Lysine RT 56°C 80°C 80°C+reduction 80°C+reduction+alkylation
K 36 + + + + + 
K 100 + + + + + 
K 156 + + + + + 
K 160 + + + + + 
K 204 + + + + + 
K 211 + + + + + 
K 228 + + + + + 
K 235 + + + + + 
K 245 + + + + + 
K 266 + + + + + 
K 374 + + + + + 
K 401 + + + + + 
K 412 + + + + + 
K 420 + + + + + 
K437 - - + + + 
K 455 + + + + + 
K 463 + + + + + 
K 498 + + + + + 
K523 - - + + + 
K559 + + + + + 
total 18 18 20 20 20 
 
Table 6. List of biotinylated lysine residues in all five different experiments of labelling BSA under 
different conditions. BSA was biotinylated with a 40 fold molar excess of sulfo-NHS-LC-biotin after 
exposure to different temperatures or after reduction with DTT. MS analysis revealed identical biotinylation 




3.9. The biotinylation reaction does not induce structural changes in the 
biotinylated protein, as detected by circular dichroism. 
 
Recently it has been reported that lysine modification by N-succinimidyl propionate 
(NSP) lacking the biotin moiety may induce conformational changes in a low molecular 
mass protein. These alterations are detectable by circular dichroism (CD) 
measurements (Gao et al., 2006). CD spectroscopy is an analytical method to provide 




conformational changes in the protein structure induced by increasing temperature or 
chemical denaturant (Greenfield, 2006). CD measures the difference between the 
absorption of left- and right- handed circularly-polarized light by proteins. The absence of 
regular structure results in zero CD intensity, while an ordered structure results in a 
spectrum containing positive and negative signals. It has been shown that the different 
secondary structures of protein including α-helix, β-sheet, and random coil provide 
different characteristic CD spectra (Sreerama and Woody, 1994; Brahms and Brahms, 
1980).  
To investigate the possibility that modification of the lysine residues with sulfo-NHS-                  
LC-biotin may induce structural changes in the BSA molecule, biotinylated and non-
biotinylated BSA were analyzed by CD spectroscopy. To analyze the potential alteration 
in the secondary structure of BSA after biotinylation, BSA was biotinylated with 
increasing molar ratio of the biotin derivative. Two portions of BSA were modified with a 
40 fold molar excess of the sulfo-NHS-LC-biotin after treatment with elevated 
temperature at 56°C and 80°C. The concentration of biotinylated and non-biotinylated 
BSA were adjusted to 50 μM. The samples were transferred to 2 mM HEPES buffer at 
pH 7.4 by extensive dialysis and subjected to analysis by CD spectroscopy. All analysis 
was performed using a Jasco-810 spectrometer with the cooperation of Dr. Uwe Linne in 
the Chemistry/Biochemistry department at Philipps-Universität Marburg. Far-UV (180-
300nm) measurements were carried out at room temperature. The observed protein CD 
spectrum is an average of CD signals from all structures and it reflects the geometric 
variability in the secondary structure.  
As shown in figure 20, the CD spectra of BSA samples are characteristic of 
macromolecules with high α-helix content which monitored by two well defined negative 
peaks at 208 and 222 nm, suggesting that the structure of non-biotinylated and 
biotinylated BSA with the biotin derivative at different molar ratios was not changed. In 
all cases, the BSA secondary structure is predominantly composed of α-helices and the 
biotinylation reaction does not induce structural changes that are detectable by CD. As 
expected, heating of BSA up to 56°C has no effect on the secondary structure of the 




after the protein was exposed to 80°C before biotinylation. The structure of BSA showed 
a shift from α-helix structure to the more open β-sheet conformation after exposure to an 
elevated temperature of 80° (Figure 20). 
The manganese stabilizing protein which has been analysed in the Gao et al., (2006) 
study is a 33 kDa protein which has a maximum of two disulfide bonds, in contrast, the 
BSA molecule forms 17 intramolecular disulfide bonds. As described these disulfide 
bonds stabilize the BSA structure against the structural alteration. The compactness and 
flexibility of BSA structure is one explanation why this protein does not undergo a 




                      
 
Figure 20. Far-UV CD spectra for different samples of BSA. Biotinylated BSA samples were 
transferred in 2 mM HEPES pH 7.4. The protein was used at concentration of 50mM at a temperature of 





3.10. Involvement of lysine residues in hydrogen bonding may decrease their 
capacity to be biotinylated. 
 
Since the biotinylation pattern was reproducible and many lysine residues could not be 
biotinylated, two possible mechanisms can be considered for the accessibility of the 
lysine residues in BSA structure to the biotin derivative. Either these lysines are involved 
in the formation hydrogen bonds with the neighbouring residues or they are buried in the 
structure of protein and the biotin derivative has no access to them because of steric 
hindrance. The position of all 20 biotinylated lysine residues were studied based on the 
homology structure between BSA and HSA. The structure of BSA and HSA show high 
similarity and the two proteins share 76% sequence identity. The heart shaped BSA 
structure consists of three alpha helices I, II and III. Each of theses domains has two 
sub-domains A and B. As shown in figure 21 and table 7 the biotinylated lysines 
distributed in the BSA structure in different helices and sub-domains. Five modified 






Figure 21. Position of biotinylated lysine residues in the primary structure of BSA. The domain 
structure of BSA was shown based on the HSA homology. The biotinylated lysine residues in the helices 
were showed in white bold. Three modified lysines which are located between the helices have been 






















K 36 IA/h1 
K 100 IA/h4 
K 156 IB/h8 
K 160 IB/h8 
K 204 Turn between IB and IIA 
K 211 Turn between IB and IIA 
K 228 Close before h1 and h2 of IIA 
K 235 IIA/h2 
K 245 Near the interface between H2andH3/IIA 
K 266 IIA/h3 
K 374 IIIB/h9 
K 401 Turn between IIB/IIIA 
K 412 Turn between IIB/IIIA 
K 420 Turn between IIB/IIIA 
K437 IIIA/h2 
K 455 IIIA/h3 
K 463 Interface between h3 and h4 of IIIA 
K 498 IIIA/h5 
K523 Between h6 and h7 of IIIA 
K559 IIIA/h8 
  
Table 7.   Positions of biotinylated lysine residues in the BSA structure.  The biotinylated lysines 
distribute in different helices and sub-domains of BSA structure. 
 
To obtain more information about the accessibility of the lysine residues in the BSA 
molecule to the biotin derivative, the structure of a homology model of BSA (primary 
accession number: P02769) was studied based on the crystal structure of human serum 
albumin (HSA) as a template. All lysine residues of BSA were examined with respect to 
a possible correlation with the following structural descriptors: the spatial accessibility of 
lysine residues the solvent accessible surface (ASA), involvement in hydrogen bonding 
and the local electrostatic potential have been calculated. The latter has been computed 
and visualized using the MOLCAD module of Sybyl7.1. All analyses have been 
performed with the cooperation of Dr. Alexander Hillebrecht at the Institute of the 
Pharmazeutische Chemie at the Philipps-University of Marburg.  
As shown in table 8, among the total 60 lysine residues in BSA sequence, 26 are 
predicted to be involved in a hydrogen bond. Out of 20 lysine residues which reacted 
with sulfo-NHS-LC-biotin in different experiments, only six lysine residues (K100, K160, 
K228, K245, K374 and K455) are involved in a hydrogen bond. However, it has to taken 




not fit the correlation are “mutated” with respect to the crystallographically characterized 
template used for homology modelling. The data suggests that the involvement of a 
lysine residue in a hydrogen bond significantly decreases the probability of biotinylation.  
The analysis did not provide clear evidence for the correlation factors of the solvent 
accessible surface and the local electrostatic potential.   
 
Lysine biotinylation ASA HB visual 
HB 





K 28 - 0.32 + 10.53 K 309 - 0.07 + 1.91 
K 36 + 0.70 - 0 K 318 - 0.48 - 0 
K 44 - 0.20 + 5.57 K 336 - 0.64 + 0 
K 65 - 0.63 - 0 K 340 - 0.48 + 10.95 
K 75 - 0.33 + 3.96 K 346 - 0.44 + 13.95 
K88 - 0.51 - 0 K 374 + 0.52 + 3.71 
K 100* + 0.62 + 20.84 K 386 - 0.56 - 0 
K 117 - 0.41 + 3.06 K 399 - 0.41 - 0 
K 130 - 0.06 + 0 K 401 + 0.70 - 0 
K 138 - 0.83 - 0 K 412 + 0.44 - 0 
K 140 - 0.43 - 0 K 420 + 0.87 - 0 
K 151 - 0.67 - 0 K 437 - 0.26 - 0 
K 155 - 0.57 + 18.09 K 455 + 0.25 + 4.77 
K 156 + 0.46 - 0 K 463 + 0.43 - 0 
K 160 + 0.32 + 0 K 489 - 0.95 - 0 
K 183 - 0.63 - 0 K 495 - 0.51 - 0 
K 197 - 0.35 - 0 K 498 + 0.59 - 1.35 
K 204 + 0.33 - 1.09 K 523 - 0.37 + 13.44 
K 211 + 0.43 - 0 K 528 - 0.79 - 0 
K 228 + 0.63 + 5.03 K 544 - 0.33 - 0 
K 235 + 0.29 - 0 K 547 - 0.20 - 0 
K 245* + 0.22 + 5.88 K 548 - 0.21 - 0 
K 248 - 0.43 + 7.76 K 557 - 0.08 + 17.53 
K 256 - 0.38 + 13.11 K 559 + 0.10 - 0 
K 263 - 0.46 + 15.42 K 561 - 0.46 + 4.57 
K 266 + 0.43 - 0 K 568 - 0.48 - 6.68 
K 285 - 0.63 - 0 K 580 - 0.78 - 0 
K 297 - 0.39 + 8.37 K 587 - 0.23 + 7.55 
K 299 - 0.63 + 12.29 K 597 - 0.57 - 0 
K 304 - 0.27 + 8.58      
 
Table 8. Analysis of all lysines of BSA for surface accessibleity and hydrogen bonding . ASA: 
accessible surface area (relative units), HB visual: formation of hydrogen bond (+) or not (-) according to 
visual inspection, HB energy: hydrogen bond energy (arbitrary units). 0 indicates an energy value below 
0.5. The asterisk marks two biotinylated residues which are mutated with respect to the template X-ray 
structure and therefore were excluded from all considerations. Bold residues are biotinylated despite their 
involvement in hydrogen bonding. All descriptors were deduced from a BSA homology model based on 






3.11. Analysis of biotinylated and non-biotinylated CA II by MS  
 
As shown in the case of BSA, the biotinylation pattern of a protein is dependent on its 
conformation. Proteins can be assigned into different classes depending on their 
quaternary structure and it is plausible that the complexity of the quaternary structure 
may affect the biotinylation pattern. A similar analysis was carried out on CA II which in 
contrast to the globular protein (BSA) is a single domain protein. CA II structure is a 
dominating ß-sheet that extends throughout the entire molecule. CA II protein contains 
18 lysine residues that are distributed throughout the entire sequence but it has no 
cysteine residues to form any disulphide bonds. The thermal denaturation curve of CA II 
has a classical sigmoid shape, with the melting temperature at 64.2°C. Only minor 
structural changes, if any, are to be expected at this pre-transition temperature. 
To investigate the biotinylation pattern of CA II,1.15 x 10 –4 moles of CA II was 
biotinylated with a 40 fold molar excess of the sulfo-NHS-LC-biotin, either at room 
temperature or subjected to elevated temperatures of 56°C and 80°C for 30 min before 
cooling and biotinylating. The biotinylated and non-biotinylated CA II were separated by 




Figure 22. Analysis of the mass of biotinylated CA II after exposure to different temperature.CA II 
was biotinylated with sulfo-NHS-LC biotin at 40 molar ratios at room temperature (RT) or after expose to 
elevated temperature and analyzed by SDS-PAGE and Coomassie staining 
 
As expected, the biotinylated CA II proteins migrate at a higher mass compared to the 
non-biotinylated sample which indicates the altering mass of protein as a result of 




temperature of 56°C (Lane 3) and 80°C (Lane 4) before biotinylation does not induce 
significant differences in the mass of the protein suggesting that the biotinylation 
patterns of CA II at room temperature and following treatment at different temperatures 
are similar. To confirm this, the Coomassie stained bands were cut and processed for 
mass spectrometry as described before. MS analysis of the unlabeled CA II showed 12 
different peptides, with masses between 973.57 and 2712.38 Dalton which covered 56% 
of CA II sequence. The identified peptides contain 9 out of the total 18 lysine residues. In 
the biotinylated CA II, 20 different peptides were identified ranging in masses from 
430.29 to 2868.53 Dalton, accounting for 66% of the protein sequence. Out of total 18 
lysine residues, 15 lysine residues were detected by MS, of which 7 residues were 
biotinylated. Peptides containing lysine residues were also found in a non-biotinylated 
form in the biotinylated sample. Heating of the protein to 80°C and cooling to room 
temperature prior to biotinylation had no effect on this pattern, probably due to rapid 
refolding of the protein (Table 9). 
 
Lysine nonbiotinylated RT 56°C 80°C 
K9 - - - - 
K18 + + + + 
K36 - - - - 
K45 + + + + 
K76 + + + + 
K80 - + + + 
K112 + + + + 
K113 + + + + 
K126 + + + + 
K148 - + + + 
K158 - - - - 
K167 + + + + 
K169 - + + + 
K171 - + + + 
K212 - + + + 
K224 - + + + 
K251 + + + + 
K260 - + + + 
total 9 15 15 15 
 
Table  9. Effect of temperature on the biotinylation pattern of CA II. Bold residues indicates the 





As shown in figure 23, the comparison of modified and unmodified CA II spectra 
indicates extra peptide peaks which are present in the biotinylated sample but absent in 
a non-biotinylated version. These new observed peptide peaks with masses of 772.46, 
787.35, 1685.96, 1729.93, 1989.00, 2049.01 and 2537.32 indicate the biotinylated 
peptides. The peptide 787.35 which is not marked in the spectra has a low intensity. All 
reported biotinylated peptides have a missed cleavage site except the peptide 
containing K260 which has no missed cleavage site and a modified lysine located at the 





Figure 23. Comparison of biotinylated and non-biotinylated CA II. One fraction of CA II was 
biotinylated with 40-fold higher mole ratio of biotin derivative. The same amount of CA II was not 
biotinylated. Two protein samples were separated by 1D gel electrophoresis and subjected to be analyzed 
by mass spectrometry. The top spectrum is from the biotinylated protein and the other one is non-






The available crystal structure of bovine CA II was examined for the putative 
accessibility of the lysine residues. The analysis in this case also suggested a 
correlation between the involvement of lysine residues in hydrogen bonding and 
decreased probability of their biotinylation. As shown in table 10, only one lysine residue 
(K224) of eight biotinylated lysine residues is involved in hydrogen bonding. 
 
 
Lysine biotinylated ASA HB visual HB energy 
K9 - 0.83 - 0 
K18 + 0.64 - 0 
K36 - 0.94 - 0 
K45 + 0.54 - 0 
K76 - 0.25 + 6.63 
K80 + 0.40 - 0 
K112 - 0.50 - 0 
K113 + 0.47 - 0 
K126 - 0.61 + 17.00 
K148 - 0.49 - 0 
K158 - 0.37 + 0 
K167 - 0.18 + 6.21 
K169 - 0.26 + 7.38 
K171 + 0.44 - 0 
K212 - 0.20 + 13.08 
K224 + 0.25 + 7.08 
K251 - 0.41 + 11.76 
K260 + 0.74 - 0 
 
Table 10. Analysis of all lysines of CA II for surface accessibleity and hydrogen bonding. ASA: 
accessible surface area (relative units), HB visual: formation of hydrogen bond (+) or not (-) according to 
visual inspection, HB energy: hydrogen bond energy (arbitrary units). 0 indicates an energy value below 
0.5. Lysine residue 224 is biotinylated despite of hydrogen bonding. 
 
 
3.12. Band III is biotinylated in infected and non-infected erythrocytes. 
 
Band III protein is an abundant membrane protein present on the erythrocyte surface 
with about 106 copies per cell. As described previously, Band III undergoes 
conformational changes upon infection with P. falciparum and these changes may be 
important for survival of the parasite (Sherman et al., 2003). Based on this observation, 




established in this study. Thus, the biotinylation patterns of Band III in infected and non-
infected erythrocytes were analysed.  
The biotinylation of BSA revealed a linear correlation between the molar ratio of the 
biotin derivative and biotinylated lysine residues, until all sufficiently reactive residues 
were saturated. To investigate the optimal concentration of sulfo-NHS-LC-biotin required 
for labelling the available lysine residues in Band III , 2 x 108 infected and non-infected 
erythrocytes were biotinylated with an increasing concentration of sulfo-NHS-LC-biotin 
(0.5 mg ml-1,1mg ml-1, 2mg ml -1).  Biotinylation was performed in the presence of 
furosemide to block NPP activity, and thus minimize internal labelling of infected 
erythrocytes. Only lysine residues that are exposed at the erythrocyte surface should 
therefore be biotinylated. The excess unreacted biotin was removed by size exclusion 
centrifugation. The biotinylated membrane fractions of erythrocytes were separated by 
SDS-PAGE, stained with Coomassie, or alternatively analyzed by immunoblotting. To 
allow identification of both Band III and Spectrin on Coomassie stained gels, membranes 
prepared from SDS-gels run under identical conditions were incubated with anti-Band III 
and anti-Spectrin antibodies, followed by detection using the ECL system. The 
monoclonal anti-Band III antibody which was used in this experiment recognizes an 
epitope in the cytoplasmic domain of the Band III molecule, approximately 20 kDa from 
the N-terminal end. This antibody recognizes Band III protein (90-100 kDa) and several 
lower molecular mass peptides migrating in SDS-PAGE gels in the regions of 60, 40 
kDa (Figure 24, Lane 1, lower panel). Spectrin could also be detected at the expected 










Figure 24. Analysis of biotinylation of membrane protein from infected (IRBC) and non-infected 
erythrocytes (RBC) with elevated concentration of biotin derivative.  2 x 108  RBC and IRBC were 
biotinylated in the presence of NPPs inhibitor using different concentrations of sulfo-NHS-LC-biotin and 
the membrane fraction was solubilized using SDS-PAGE sample buffer and separated in a 7.5% SDS-
PAGE and analyzed by Coomassie staining or alternatively analyzed by anti-Band III and anti-Spectrin. 




As shown in figure 24, although there are large differences in the total protein content 
and pattern of samples derived from infected or non-infected cells (Lanes 2-5 and Lanes 
10-13), no significant differences in the migration behaviour of Band III could be 
visualised by Coomassie staining. This suggested that either Band III is not biotinylated, 
or that only few lysine residues are biotinylated. The migration of Band III after labelling 
with an elevated concentration of biotin derivative (Lanes 3,4,5 and Lanes 11,12,13) 
does not change significantly compared to the non-treated control (Lane 2 and Lane 10). 
This indicating that biotinylation of Band III results in only minimal, or non-existent, 
modification of lysine residues, even when using increasing concentrations of the biotin 
derivative. Immunoblotting using alkaline phosphatase-conjugated SAV on nitrocellulose 




change in Band III migration after treatment with increasing biotin concentrations could 
not be detected by this method, supporting a minimal biotinylation of the Band III protein 
(Figure 24, Lanes 6-9 and Lanes 14-17).  Additionally, the lower molecular mass 
peptides detected by the anti-Band III antibody can also be detected by anti-biotin 
(Figure 24).  
To confirm that internal membrane proteins were not biotinylated in all experiments, the 
biotinylation status of spectrin was examined. Spectrin was visualised firstly with anti-
spectrin antibody. This antibody reacts specifically with α and β chains of human 
erythrocyte spectrin which migrate at ~ 280 kDa in the gel. As expected, a strong signal 
at ~ 280 kDa was detected using anti-Spectrin antibodies, verifying that the transfer of 
this protein to the nitrocellulose membrane was efficient (Figure  24, Lane 1, upper 
panel).The same membrane was then probed with alkaline phosphatase conjugated 
streptavidin. As shown in figure 24, in comparison to the signal migrating at the height of 
Band III only a weak signal can be visualised at the molecular weight of spectrin, 
suggesting only a minimal, if any, biotinylation of this protein (Figure 24, Lanes 6-9 and 
Lanes 14-17).  To confirm this, Coomassie stained bands corresponding to spectrin was 
cut, digested and analyzed by mass spectrometry. MS data in this case identified 
Spectrin, but no biotinylated Spectrin-derived peptides were found. 
 
3.13. MS analysis identifies Band III  
 
Band III is a multi-spanning membrane protein with 11-14 transmembrane domains. 
According to the predicted topology, 5 domains are exposed extracellularly. While three 
domains are composed of less than 10 amino acid residues, two domains (543-568 and 
626-663) are composed of 26 and 38 amino acids respectively. One additional domain 
(802-835) is predicted to exhibit enhanced flexibility which can vary between an 
extracellular and intracellular topology. Since only a portion of tryptic peptide of a protein 
can be detected under experimental conditions by mass spectrometry, In silico digestion 
of Band III was performed using ExPASY proteomic server to generate theoretical 
peptides. The following parameters were used in the prediction: all cysteines were 




were used for all amino acid residues, and the maximum number of missed cleavage 
sites allowed was one. Theoretical digestion of Band III generates approximately 200 
peptides with masses in the range of 505.31 to 8960.86 Da, almost half of which contain 
at least one lysine residue.  To analyze Band III under experimental conditions, a 
Coomassie stained band corresponding to the highest molecular weight Band III signal 
was excised from biotinylated and non-biotinylated RBC and analyzed by mass 
spectrometry. Band III MS spectra from biotinylated and non-biotinylated samples are 
shown in figure 25. Three peaks with m/z 1028.605, 1612.766 and 2864.188 could be 




Figure 25.  MS analysis of biotinylated and non-biotinylated RBC. 2 x 108  RBC were biotinylated and 
the membrane fraction was separated by SDS-PAGE. The stained band were cut and analyzed by mass 
spectrometry in reflectron mode. The arrows marked the extra peaks in biotinylated Band III which indicate 
the biotinylated peptides. 
 
MS analysis together with a database search verified the two samples as derived from 




shown in figure 26. 70% of the identified peptides are located at the N-terminus of 
protein, the remainder derived from the C-terminus. A peptide corresponding to amino 
acids 647 - 656 (which are in loop 4) and 880 - 901 (located within the cytoplasmic 
domain of the C-terminus) was identified in both samples. Three extra peaks were 
observed in the biotinylated Band III sample. Database searches identified these peaks 
as corresponding to biotinylated peptides covering amino acids 818 - 827 and 828 - 832, 







Figure 26. Comparisons of the detected peptides in biotinylated and non-biotinylated Band III. The 









3.14. The peaks found in non-biotinylated samples are falsely identified by    
         database searches as corresponding to a biotinylated peptide.  
 
The comparison of spectra of the biotinylated and non-biotinylated Band III revealed 
some extra peaks only found in biotinylated samples suggesting that these correspond 
to peptides containing biotinylated lysine residues. However database searches 
performed with spectra derived from the non-biotinylated sample also predicted the 
presence of a biotinylated peptide. As (excluding contamination or experimental error) 
this cannot be the case, the possibility of a false database prediction was investigated. 
As shown in figure 27, a peak with m/z 1934.012 was seen in spectra derived from both 
the biotinylated and non-biotionylated Band III samples. This result was reproducible, as 
this peak was seen in three independent experiments. Database searches including 
sulfo-NHS-LC-biotin as an optional modification predicted the sequence 
(VYVELQELVMDEK) corresponding to amino acids 57 – 69 with the K69 being 
biotinylated. An alternative search with the same parameters but without the biotin 
modification predicts a different peptide (LQEAAELEAVELPVPIR) corresponding to 
amino acids 247 - 263.  This second peptide does not contain a lysine residue. The 
theoretical mass of the peptide is 1877.08 and was reported with the 







Figure 27. Zoom of section of MS spectra of biotinylated and non-biotinylated RBC including peak 
with m/z 1934. The peak m/z 1934 was detected in both labelled and unlabeled samples.  
 
To verify which of these predictions is correct; peaks with m/z 1877.346 and 1934.281 
from the non-biotinylated Band III sample were analyzed by tandem mass spectrometry 
(Figure 28). MS/MS analysis confirmed that the peak with m/z 1934.281 corresponded 
to a non-biotinylated peptide with sequence LQEAAELEAVELPVPIR. An ion 
corresponding to the biotin tag (mass 340 Da) was not found. Comparison of the MS/MS 
spectra verified that the only difference between these two predicted peptides is the 
carbamidomethylation of the leucine residue (L246) at the N-terminus. This N-terminal 
carbamidomethylation most likely occurred during sample preparation. A peptide with 
m/z 1934.281 was also seen in the spectra derived from the biotinylated sample. MS/MS 
analysis showed that this peak also corresponds to the non-biotinylated peptide. 
Additional support for this interpretation of the data is that all labelling with non-
permeable biotin derivatives was performed in the presence of furosemide to prevent 










Figure 28. MS/MS analysis of peaks with m/z 1877.34 and 1934.24 from non-biotinylated RBC. 
Peptides with m/z 1877.34 and 1934.24 were subjected to tandem mass spectrometry and the generated 
fragments were compared. The comparison of MS/MS analysis and database search indicated the N-







3.15. Biotinylated Band III peptides were rarely detected.  
  
Band III contains a total of 29 lysine residues evenly distributed throughout the primary 
protein sequence. Several biochemical studies have investigated the position of these 
residues in relation to the membrane topology of the protein (Kang et al., 1992; Okubo et 
al., 1994; Kuma et al., 2002; Abe et al., 2004). These data are summarised in figure 29. 
Eight lysine residues are located within the N-terminal cytoplasmic domain, 7 lysines in 
the C-terminal cytoplasmic domain and three lysines within the transmembrane 
domains. 9 lysine residues reside in the extracellular loops, four of which are located in 
one of two large loops. Four further lysine residues are found in the flexible loop 












Figure 29. The distribution of lysine residues in the Band III sequence. Band III has a total 29 lysine 
residues (K), marked by red circles. Lysines which are exposed to the surface of erythrocytes are marked 
by blue colour (Modified from Zhu et al., 2005). 
 
 
To investigate the biotinylation pattern of Band III in infected and non-infected 
erythrocytes, Coomassie stained bands corresponding to the full-length protein were 
excised and analyzed by mass spectrometry and tandem mass spectrometry. In all three 
experiments the protein was identified as Band III with a sequence coverage between 
15% and 30%. MS and database analysis of biotinylated Band III protein from non-




shown in table 11, 18 lysine residues were predicted in this analysis. In the IRBC 
sample, 14 peptides were predicted. The peptides were distributed in the same mass 
range as those from the non-infected sample and contain 15 lysine residues. 7 lysine 
residues in the RBC and 6 lysines in the IRBC sample are predicted to be found on the 
extracellular side of the erythrocyte membrane. Of these, four were found non-
biotinylated in both the IRBC and RBC samples.  The residue K851 was only found in 
RBC in a non-biotinylated form. Out of the total 29 lysine residues in Band III 9 lysines 
could not be identified in either the RBC or IRBC samples. 
 
Lysine residue RBC IRBC Position biotinylated 
56  -  - internal  - 
69  +  + internal  - 
116  +  - internal  - 
160  -  - internal  - 
174  +  + internal  - 
219  -  + internal  - 
353  +  + internal  - 
360  +  + internal  - 
430  -  - external  - 
539  -  - TM  - 
542  +  + TM  - 
551  +  + external  - 
562  -  - external  - 
590  -  - internal  - 
592  +  + internal  - 
600  +  + internal  - 
631  -  - external  - 
639  +  - external  - 
691  -  - internal  - 
695  +  - internal  - 
698  +  - internal  - 
743  -  + external  - 
757  -  + TM  - 
814  +  + external  - 
817  +  + external  - 
826  + + external  RBC 
829  +  + external RBC/IRBC 
851  +  - TM  - 
892  +  + internal RBC/IRBC 
total 18 15 29 3 
 
Table 11.Listing of identified lysine residues of Band III in non-infected erythrocytes (RBC) and 
infected erythrocytes (IRBC) after biotinylation. 2 x 108 erythrocytes were biotinylated with different 
concentrations of sulfo-NHS-LC-biotin and the membrane protein fraction was separated by 1D gel 





MS spectra analysis showed no variation in the biotinylation pattern between 
experiments carried out with three different biotin concentrations indicating that an 
increase in biotin derivative concentration does not result in an increase in the number of 
biotinylated lysine residues. In the case of infected erythrocytes only two biotinylated 
lysine residues (K829, K892) could be detected. In non-infected erythrocytes in addition 
to K829 and K892, K826 is also biotinylated (Figure 30 A, B and C). Peaks 
corresponding to the peptides containing non-biotinylated lysine residues K826 and 
K892 were also detected in the MS spectra of the biotinylated sample. The peak of 
unmodified peptide containing lysine K829 is unfortunately located in the peak cluster 
from the matrix and could therefore not be detected. The peaks corresponding to the 
biotinylated peptides in the MS spectra have very low intensities in comparison to the 
unmodified form. All three biotinylated peptides are predicted to contain one missed 







Figure 30. Zoom of sections MS spectra for Band III from infected erythrocytes and non-infected 
erythrocytes. In non-infected erythrocytes (RBC) lysine residues K826, K829 and K892 corresponding to 
m/z 1612.76, 1027.700 and 2864.19 respectively are biotinylated. In infected erythrocytes biotinylated 
K829 and K892 can be detected but not K826. The arrow in Figure A shows the absence of the peak 
corresponding to the peptide containing biotinylated K826 in infected erythrocytes(IRBC). 
 
 
Further analysis of the K826 and K829 containing peptides by tandem mass 
spectrometry identified the individual biotinylated lysine residues. MS/MS Analysis of 
peptide with m/z 1612.87 confirmed the sequence (YHPDVPYVKR) and the position of 
the modified lysine residue (Figure 31). In comparison to the theoretical mass of the 




to the mass of the biotin derivative. The biotin tag is detectable in spectra. In addition, 





Figure 31. MS/MS analysis of peptide 1612.81 that is found only in the biotinylated Band III in RBC. 
The fragment ions of peptide with m/z 1612.81 confirmed the sequence (YHPDVPYVKR) of the peptide 
and modified lysine residue (K826). The spectrum contains the biotin peak at mass 340 Da and includes 
one missed cleavage site. 
 
MS/MS analysis of peptide with mass 1028.54 revealed the corresponding sequence of 
the peptide (VKTWR) containing a biotinylated lysine residue (Figure 32). A 339.14 Da 
difference between the observed (1028.54) and theoretical mass (689.4093) of the 




biotin tag is detected in spectra. MS/MS analysis confirmed that the sequence contains 




Figure 32.  MS/MS analysis of peptide 1028.54 that is found in the biotinylated Band III in RBC and 
IRBC. The generated fragments revealed the corresponding short sequence of peptide (VKTWR) 
containing biotinylated K829. The spectrum also reveals a peak corresponding to the mass of the biotin 
tag. 
 
To confirm the biotinylation of K892 in the peptide with m/z 2864.840, the peptide was 
also subjected to tandem mass spectrometry. Despite three attempts, the low intensity 
and amino acid composition of this peptide did not result in good fragmentation ions and 
subsequently protein identification based on the fragments of peptide was not possible. 
MS/MS showed only significant fragment ion at m/z 339.414 which could correspond to 






3.16. Biotinylation does not affect the ionization efficiency of peptides 
 
As described before, in the analysis of the biotinylation a pattern of Band III, the modified 
peptides were detected with low signal intensity in comparison to peptides containing 
non-biotinylated lysine residues. To determine if biotinylation has an effect on ionization 
of peptides during the MALDI process, a synthetic peptide with the sequence 
corresponding to the Band III peptide YHPDVPYVK (818-826) mass 1116.293 Da was 
biotinylated. The peptide was biotinylated with an equimolar concentration of sulfo-NHS-
LC-biotin and subjected to mass spectrometry. The result shows that biotinylation does 
not reduce the ionization capacity during the MALDI process (Figure 33).  
 
Figure 33.  Biotinylation of synthetic Band III peptide using sulfo-NHS-LC-biotin. A synthetic peptide 
corresponding to the Band III peptide YHPDVPYVK (818-826) with m/z 1116.293was biotinylated with an 
equimolar concentration of sulfo-NHS-LC-biotin and subjected to mass spectrometry. a: the non-
biotinylated peptide; b: biotinylated peptide using equimolar biotin derivative; c: biotinylated using molar 







Biotinylation with a molar excess of the biotin derivative leads to complete biotinylation. 
The non-biotinylated peptide is absent from the spectra and two peaks corresponding to 
the biotinylated peptides are detected  with m/z 1456.955 Da corresponding to the 
addition of a single biotin molecule and m/z 1796.620 Da corresponding to the addition 
of 2 biotin molecules (Figure 33c). The biotinylation reaction in this peptide occurs at the 
epsilon amino group of the lysine residue or at the N-terminus of the peptide.  
In spite of these findings, the lack of detection of biotinylated Band III peptides at high 
intensities in the preceding analysis may be due to other factors e.g. steric hindrance 
which leads to inefficient biotinylation and detection of the biotinylated peptides. 
Alternatively it could be due to the hydrophobic nature of the peptides, which has been 




















Chemical modification of proteins and peptides with the hydrophilic reagent sulfo-NHS-
LC-biotin derivative is one of the most commonly used molecule tagging method in 
biochemical and biomedical research. The ester active group of these derivatives reacts 
with the primary amines of proteins and/or the epsilon amino group of lysine residues 
forming an amide bond. The high affinity and specificity of the interaction of biotin to 
avidin and its bacterial homologue streptavidin, is regarded as the strongest non-
covalent, biological interaction known with a dissociation constant, Ka= 1015 M-1. The 
biotin labelled proteins can be easily visualised with streptavidin derivatives, or they can 
be captured on streptavidin sepharose beads. The biotin labelled peptides can be 
purified, although due to the high stability of the biotin-streptavidin interaction, care must 
be taken to find effective elution conditions that have no effect on downstream analysis, 
especially mass spectrometry.  
 
In this current study, I investigated whether biotinylation followed by mass spectrometry 
can be used as a general method to study both protein structure, and alterations in 
protein structure in response to external influences. To this end ,biotinylation patterns of 
three model proteins (bovine serum albumin (BSA), bovine carbonic anhydrase II (CA II) 
and erythrocyte plasma membrane protein Band III) were systematically analysed by 
mass spectrometry. To investigate whether conformation changes in the protein 
structure are reflected by changes in biotinylation patterns, these experiments were also 
carried out under different conditions to determine if specific, experimentally induced 
conformational changes result in a reproducible biotinylation pattern of lysine residues. 








4.1. Biotinylated lysine residues can be detected by MS and MS/MS analysis 
 
Analysis of the biotinylated peptides by mass spectrometry showed that biotinylation of 
lysine residues does not affect the efficiency of ionization of peptides in MALDI-TOF 
mass spectrometry and that the modified peptides were detectable by MS analysis. 
Furthermore, tandem mass spectrometry of the modified peptides together with a 
database search for the amino acid sequences confirms the sequence of the peptides. 
As shown in this study, MS/MS analysis of modified peptides reveals a characteristic 
mass peak at 339.16 Da corresponding to the mass of the biotin tag after breakage of 
the amide bond between the lysine residue and the biotin derivative, thus providing 
evidence for biotinylation. The quality of the MS/MS spectra and the intensity of the 
biotinylated peptides play an important role in such analyses.  
 
 4.2 .The biotinylation of protein is reproducible but incomplete 
 
The mass spectrometry of the biotinylated BSA showed that biotin labelling of the 
protein is highly reproducible. The biotinylation pattern of a protein contains a number of 
lysine residues which are preferentially labelled and uniformly distributed in the protein. 
Exactly which lysine residues which can be labelled depends on the concentration of the 
biotin derivative and the protein structure. In the case of BSA the results showed that out 
of 60 lysine residues in the primary structure of BSA, only 18 lysine residues can be 
modified after biotinylation at room temperature.  Furthermore, the mass spectrometry 
results in linear-TOF and reflectron mode indicated that the biotinylation of protein is not 
complete even when a high molar excess concentration of the biotin derivative is used in 
the biotinylation reaction. The incomplete biotin labelling could be attributed to the 
conformation of the protein, where some of the lysine residues are inaccessible to the 
biotinylating agent.  
 
Recently, Huang et al., (2004) used hydrophilic and hydrophobic cross-linkers and 
subsequent mass spectrometry to probe the tertiary structure of BSA. These included 
Bis (Sulfosuccinimidyl) suberate (BS3), a cross linker which has a reaction mechanism 
4. Discussion 
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similar to that of sulfo-NHS- LC-biotin. The structure of the reagent is shown in figure 34. 
BS3 is a water-soluble, non-cleavable and membrane impermeable cross-linker that 
contains an amine-reactive N-hydroxysulfosuccinimide (NHS) ester. NHS esters react 
with primary amines in the side chain of lysine residues or the N-terminus of each 
polypeptide and form stable amide bonds at pH 7-9. BS3 has a spacer arm in with 11.4 
Angstroms in length. Huang et al., (2004) used BS3  to crosslink the lysines in the 
hydrophilic or surface regions in the BSA structure. The unmodified and BS3 modified 




Figure 34. Structure of cross-linkers was Bis (sulfosuccinimidyl) substrate.The NHS ester groups at 
each end joined with an 8 carbon spacer arm with length of 11.4 Angstrom (modified from Pierce). 
 
A comparison of the data from Huang et al., (2004) experiment and this study revealed 
some differences (Table12). Huang et al., (2004) identified a total of 20 modified lysine 
residues using  BS3  cross-linker, 13 of which were also labelled with sulfo-NHS-LC- 
biotin. Three of the modified residues (K138, K140 and K495) identified in that study 
were detected only in a non-biotinylated form in all of the experiments using sulfo-NHS-
LC-biotin. One lysine residue (K88) was not detected in this current study using sulfo-
NHS-LC-biotin labelling, and one residue (K399) was detected only once, in its 
biotinylated form. Two residues (K437 and K523) were also labelled with sulfo-NHS-LC- 
biotin however only after exposure of BSA to high temperature. Five further lysine 
residues were identified in a biotinylated form in this study which were not detected by 
Huang et al., (2004). 7 lysine residues (K204, K211, K228, K245, K412, K420 and K463) 
which were modified by sulfo-NHS-LC- biotin, are (based on the Huang et al study) 






          current study       Huang et al.,2004 
   Lysine LC-biotinylation at RT LC-biotinylation at 80°C BS3-cross linking 
K 36  +  +   
K 88        + 
K100  +  +   
K138        + 
K140        + 
K 156  +  +    + 
K 160  +  +    + 
K 204  +  +    + 
K 211   +  +    + 
K 228  +  +    + 
K 235  +  +    + 
K 245  +  +    + 
K 266  +  +   
K 374  +  +    + 
K 399        + 
K 401  +  +    + 
K 412  +  +    + 
K 420  +  +    + 
K 437    +    + 
K 455  +  +    + 
K 463  +  +    + 
K 489        + 
K 495        + 
K 498  +  +   
K 523    +   
K 559  +  +   
Total 18 20 20 
 
Table 12. The comparison of identified labelled lysine residues in current study and Huang et al., 
(2004) study. The majority of the modified lysine residues were identical in both studies, underscoring the 
reproducibility of the biotinylation reaction. RT: room temperature; BS: Bis (Sulfosuccinimidyl) suberate 
cross linker.  
 
   
Differences in the experimental procedure between Huang et al., (2004) and this current 
study make direct comparison of the labelling status in these two experiments difficult. 
Nevertheless, although two different ionization conditions (ESI vs. MALDI) and different 
labelling reagents (BS3 or sulfo NHS-LC-biotin) were used, both the approach of Huang 
et al., and our own approach identified almost identical peptides. Additionally, the 
modification status of the lysine residues in these peptides were almost identical in both 




4.3 .The conformational changes are reflected in the biotinylation pattern 
 
Since the biotinylation pattern of the protein is dependent on  protein conformation; any 
alteration in the protein structure is predicted to lead to an alternative biotinylation 
pattern. To study this possibility, BSA was subjected to higher temperatures and 
treatment with reducing agents, conditions which induce both reversible and irreversible 
conformational changes of the protein structures. 
 
As described before, the heat denaturing of BSA molecule happens in two significant 
stages: up to 65°C the conformational change of BSA is reversible and the protein will 
return to the native state after cooling. Beyond 65°C, the irreversible alteration is 
induced in the structure but does not necessarily result in a complete destruction of the 
protein structure (Lin et al., 1976; Wetzel et al., 1980). During the heating above 65°C, 
the alpha helix can be partially unfolded and converts to the beta-sheet. This situation 
can be amplified by cooling (Wetzel et al., 1980). Based on these concepts, the 
biotinylation patterns of BSA at room temperature and after heating at 56°C before 
biotinylation were identical. In contrast, exposure of BSA to the temperature of up to 
80°C before biotinylation results in the detection of two additional biotinylated lysines. 
These results show that two new lysine residues were labelled after artificially inducing 
conformational changes, and that these changes are detectable with mass 
spectrometry.  
 
Since the reduction of disulphide bonds in the structure of protein can induce the 
unfolding form, in this study the effect of reducing agents on the biotinylation pattern of 
BSA has been examined. MS analysis showed that no new lysine residues are 
biotinylated after reduction of BSA. The result confirms a previous study that suggested 
that most of the disulphide bonds in BSA are located almost between helical segments 
in the protein structure, where they are protected from reducing agents at neutral pH 





4.4. The biotinylated lysine residues are resistant to trypsin cleavage 
 
Since biotinylation occurs at the protonated epsilon amino group of the lysine residue, in 
this study, the effect of biotinylation on the recognition and trypsin cleavage of lysine 
residues was analyzed. Using an effective and compatible elution protocol, quantitative 
recovery of biotinylated peptides from streptavidin sepharose were performed and the 
modified peptides were analyzed by mass spectrometry and tandem mass spectrometry. 
Data showed that approximately all of the biotinylated peptides which were identified in 
this study contained a missed cleavage, suggesting that trypsin cleavage at the C-
termini of lysine residues is inhibited upon biotinylation.  
 
4.5. Involvement of lysine residues in hydrogen bonding may prevent the 
biotinylation 
 
 Since only a certain number of lysine residues could be modified by biotinylation after 
different treatments in this study, it was suggested that the other lysines were not 
accessible to the modifying reagent. These non-biotinylated lysine residues are 
suggested to form hydrogen bonds with other residues or they are superficially buried in 
hydrophobic regions of the protein where they are shielded from the biotin derivative 
reagent through steric effects. Data in this study confirmed that the involvement of a 
lysine residue in a hydrogen bond significantly decreases the probability of biotinylation.  
The accessibility of the lysine residues in BSA structure to biotin derivative was also 
analyzed, the results showed no correlation between predicted accessibility of lysine 
residues to the surface and biotinylation. However, Huang et al., (2004), based on cross 
linking experiments that lysine residues which reside at the interface between helices or 
turns between domains are exposed on the surface of the BSA molecule. Based on this 
prediction, seven biotinylated lysine residues (K204, K211, K228, K245, K412, K420 and 






4.6. Only few biotinylated lysine residues in Band III structure are detected 
 
After showing that alteration in biotinylation pattern can be detected by mass 
spectrometry, the biotinylation of Band III from infected and non-infected erythrocytes 
was compared. Various proteomics studies have previously indicated that the 
identification of hydrophobic membrane proteins by mass spectrometry is problematic. 
Low sequence coverage of membrane proteins is a recognised phenomenon in such 
proteomics approaches (Santoni et al., 2000; Low et al., 2002; Abe et al., 2004). 
 
The Band III protein is divided into three regions: a hydrophilic, cytoplasmic domain 
(residues 1- 403) which interacts with a variety of membrane and cytoplasmic proteins; a 
hydrophobic, transmembrane domain (residues 404-882) which facilitates the anion 
transport and an acidic, C-terminal domain (residues 883-911) which interacts with 
carbonic anhydrase. The majority of the peptides which are located in the highly 
hydrophobic transmembrane domain of Band III could not be detected in this study. The 
identification of Band III with low sequence coverage could be attributed to the high 
hydrophobicity and low solubility of the protein, resulting in decreased trypsin 
accessibility to the cleavage sites. In addition, it has been shown that the hydrophobic 
nature of the peptides negatively affect the ionization in MALDI due to the low proton 
affinity (Olumee et al., 1995). The low sequence coverage after peptide mass 
fingerprinting may also be due to the limited number of trypsin cleavage sites (lysine and 
arginine residues) within the protein sequence, resulting in the generation of only a small 
number of tryptic peptides.  
 
Peptide mapping of the Band III protein using different chemical modification showed 
that the labelling of exposed lysine residues in the structure of Band III is not complete 
and only few lysine residues can be labelled with modifying reagents because of either 
function or structure of lysine residue in the protein structure (Kang et al., 1992; Okubo 




Analysis of biotinylation pattern of Band III in normal and South-east Asian ovalocytosis 
(SAO, containing abnormal Band III) erythrocytes after modification using sulfo-NHS-SS-
biotin produced identical results (Kuma et al., 2002). The authors labelled the available 
lysine residues in the transmembrane domains of Band III with a biotin derivative in a 
final concentration of 0.1-1 mg/ml. The transmembrane domains were obtained after 
removing the cytosolic N-terminus domain of the protein by trypsin treatment and 
separation from peripheral membrane proteins by alkali treatment. The membrane 
domains of protein were digested with trypsin and analyzed by MALDI-TOF mass 
spectrometry. The results showed that only two lysine residues (K892 and K814 / K817) 
were modified in normal Band III where the biotinylation of K814 and K817 could not be 
distinguished because they were identified in the same peptide. The Band III protein in 
the SAO membrane contains three extra modified lysines (K851, K691 and K757). In 
comparison to the Kuma et al., (2002) analysis, our study also detected K814 and K817, 
but only in a non-biotinylated form. K851 was only found in RBC and K757 was 
detectable only in the IRBC sample, both in a non-biotinylated form. Lysine residue 
K691 was not detected at all.  
 
These findings are also consistent with the cross-linking experiments data. It has been 
shown that the stilbene compounds DIDS and H2DIDS which covalently react with a 
lysine residue, have distinct binding site in Band III. H2DIDS reacts with K539 and K851 
in Band III, and induces an intra-molecular cross-linkage between them (Okuba et al., 
1994). DIDS also reacts with K539, but no cross-link with K851 is formed except under 
partial denaturing conditions (Kang et al., 1992). In another study, Abe et al. (2002) used 
further stilbene compounds 4-Acetamido-4′-isothiocyanatostilbene-2,2-disulfonic acid 
(SITS) and 2,4-Dinitrofluorobenzene (DNFB) to modify Band III. The authors showed 
that SITS modified only K539 and DNFB labelled K590 and K539.  
The lack of detection of biotinylated Band III peptides at high intensities in our analyses 
may be due to other factors like steric hindrance, leading to only a sub-set of lysine 
residues being biotinylated. In fact, out of a possible 29 lysine residues (9 of which are 
predicted to be exposed at the erythrocyte surface) within the Band III protein sequence, 
only 3 could be detected in a biotinylated form. In addition the chemical modification and 
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enzymatic cleavage of peptides containing these biotinylated residues are problematic 
because of hydrophobic properties. 
 
4.7. The biotinylation pattern of Band III is different in RBC and IRBC 
 
Our analyses revealed that one specific lysine residue was only found in a biotinylated 
form in the non-infected red blood cell sample (Figure 35). After surface biotinylation of 
nno-infected erythrocyte, three lysine residues were found to be biotinylated. Two of 
these residues (K826 and K829) are located in the prominent flexible loop and one 
lysine (K892) resides in a predicted intracellular domain. In contrast, in infected 
erythrocyte only two lysine residues were biotinylated (K829 and K892). Importantly, 
biotinylated K826 could not be detected in the IRBC sample, but K826 containing 




Figure 35. Biotinylation pattern of the highly flexible domain of the Band III molecule. The 
underlined lysine residues K814 and K817 were detected in both infected and non-infected erythrocytes 
and were not biotinylated. K851 was detected only in RBC and was not biotinylated. K829 and K892 were 
detected in both RBC and iRBC and were biotinylated. K826 was detected in both RBC and iRBC but was 
biotinylated only in RBC. * indicates the biotinylated lysine residue in RBC and # shows the biotinylated 




Lysine K826 is located in the extracellular flexible loop (Kuma et al., 2002; Zhu et al., 
2003) whose lysine and histidine residues have been shown to be required for anion 
transport of Band III (Muller et al., 1995). Peptides containing K826 and K829 are thus 
found in a region of Band III which appears to be important for protein function. This 
region is known to mediate the removal of aged erythrocytes by exposure of the 
senescent antigen (Kay et al., 1990). K826 is also positioned in a region that is 
differentially recognized in non-infected and in infected erythrocytes by a monoclonal 
antibody (Winograd and Sherman, 2004). It was shown that synthetic peptides with 
residues 821-834 were able to inhibit the adhesion of P. falciparum infected erythrocytes 
in vitro and to affect sequestration (Crandallm and Sherman, 1994). The amino acids 
807-826 are also identified as the core region of the Band III receptor for parasite MSP1 
(Goel et al., 2003).  
At this point there is no explanation for the biotinylation of K892, which is predicted to be 
intracellular. It has been suggested that processing of the C-terminus or its association 
with other host proteins like carbonic anhydrase (Mori et al., 1995; Vince and  
Reithmeier, 1998, 2000) possibly results in its surface exposure. This observation 
should be further investigated given that the C-terminus of the protein has been 
implicated in the physiological process other than anion transportation.  
 
As shown in this study, analysis of the altered biotinylation pattern for the Band III 
molecule in non-infected and infected erythrocytes suggests a conformational change in 












4.8. Future directions and implications of this study 
 
This study has established the protocols for the analysis of conformational changes in 
protein structure. The method of choice was labelling with biotin derivates, followed by 
mass spectroscopy. Applying these methods show that changes in conformation can be 
detected using this method, and used further, the established protocol was used to verify 
changes in the structure of the Band III protein upon infection of the human erythrocyte 
with P. falciparum. Although in this particular case, the method used to study the 
influence of a pathogen on its host cell, it is envisaged that this method may also be 
applied to study changes in protein conformation in other cells and systems. Thus, the 
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The biotinylation patterns of two soluble model proteins (BSA and CA II) were analyzed 
under different conditions. In a first step these proteins were biotinylated with an 
increasing molar excess of a biotin derivative. In this case increases in biotin 
concentration led to an increase in the number of biotinylated lysine residues until  a 
point of saturation was reached. A further increase in biotin concentration did not result 
in additional lysine residues being biotinylated. The biotinylation pattern was 
reproducible and under any given conditions, only specific lysine residues are 
biotinylated. 
After showing that the biotinylation of proteins is specific and reproducible, the same 
approach was used to map artificially induced conformation changes in BSA and CA II. 
These proteins were subjected to elevated temperatures that induce conformation 
changes. The biotinylation pattern of these proteins at room temperature and after 
exposure to 80°C was compared. For BSA, heating results in the biotinylation of two 
additional lysine residues. This is most likely due to conformation changes in the protein 
structure induced by the high temperature. In the case of CA II there was no difference 
in the biotinylation pattern of the protein at room temperature and at 80°C.  
Having established that biotinylation patterns can be used to reliably detect 
conformational changes in protein structure, the biotinylation pattern of Band III (a trans-
membrane protein of the human erythrocyte plasma membrane) in infected and non-
infected erythrocyte was analyzed. These experiments confirmed previous observations 
that this protein undergoes a conformational change upon infection. The biotinylation 
pattern was different between RBC and IRBC in respect to a single lysine residue which 
is biotinylated only in RBC. These results suggest that, upon invasion by P. falciparum, 
the Band III protein undergoes conformation changes which are probably important for 
the survival of the parasite within the host cell.  




Das Biotinylierungsmuster zweier löslicher Proteine (BSA und CA II), sowie das des 
Erythrozytenmembranproteins Bande III wurde unter unterschiedlichen Bedingungen 
analysiert. Im ersten Schritt wurden diese Proteine mit einem Überschuss an Biotin in 
einem molaren Verhältnis biotinyliert. Für die löslichen Proteine führt eine Erhöhung der 
Biotinkonzentration zu einer Zunahme der Anzahl an biotinylierten Lysinresten bis zu 
einem Punkt der Sättigung. Eine weitere Erhöhung der Biotinkonzentration führt nicht zu 
zusätzlich mit Biotin markierten Lysinresten. Das Biotinylierungsmuster dieser beiden 
löslichen Proteine ist reproduzierbar und zeigt unter allen gewählten Bedingungen eine 
Biotinylierung spezifischer Lysinreste.  
Nachdem gezeigt war, dass die Biotinylierung der Proteine spezifisch und 
reproduzierbar ist, wurde die gleiche Methode gewählt, um künstlich verursachte 
Konformationsänderungen in BSA und CA II anhand eines veränderten 
Biotinylierungsmusters zu zeigen. Diese Proteine wurden erhöhten Temperaturen 
ausgesetzt, um eine Konformationsänderung hervorzurufen, und anschliessend wurden 
die Biotinylierungsmuster bei Raumtemperatur und 80 °C miteinander verglichen. Bei 
BSA führt die Erhitzung auf  80 °C zu einer Biotinylierung von zwei zusätzlichen 
Lysinresten. Dabei ist es wahrscheinlich, dass die durch die Erwärmung verursachte 
Konformationsänderung die beobachtete Änderung des Biotinylierungsmusters zur 
Folge hat. Im Fall von CA II gibt es keinen Unterschied das Biotinylierungsmusters 
zwischen Raumtemperatur und 80 °C. 
Da es Hinweise dafür gibt, dass sich die Konformation des Bande III Proteins in der 
Plasmamembran von Erythrozyten nach einer Infektion mit P. falciparum verändert,   
wurden intakte infizierte und nichtinfizierte Erythrozyten biotinyliert, um etwaige 
Unterschiede in den Biotinylierungsmustern festzustellen. Das Biotinylierungsmuster des 
Proteins unterschied sich zwischen RBC und IRBC nur in einem einzelnen Lysinrest, der 
nur in RBC biotinyliert ist. Diese Beobachtung bestätigt die Annahme, dass Bande III 
nach der Infektion durch P. falciparum eine Konformationsänderung erfährt und erlaubt 
es, die Position dieser Veränderung einzugrenzen. 
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Sulfosuccinimidyl-6-(biotinamido) hexanoate and deriva-
tives thereof covalently bind to the -amino group of lysine res-
idues. Our observation that access of the biotin derivative to
specific lysine residues depends on conformational properties
of the entire polypeptide chain prompted us to investigate
whether differential biotinylation patterns of a protein can be
used as indicators for conformational changes. Bovine serum
albumin is a soluble protein with characteristic unfolding kinet-
ics upon exposure tohigh temperature. First, we show that bioti-
nylation patterns of proteins are highly reproducible. Second,
we demonstrate by mass spectrometry and tandem mass spec-
trometry that unfolding of the protein correlates with the acces-
sibility of the biotin derivative to specific lysine residues. We
have applied this experimental strategy to the analysis of a
cell-surface protein, viz. the human band 3 anion exchanger
of erythrocytes infected with the malaria parasite Plasmo-
dium falciparum. We found that Lys826 in a highly flexible
loop can be biotinylated in non-infected (but not infected)
erythrocytes, confirming earlier observations (Winograd, E.,
and Sherman, I. W. (2004) Mol. Biochem. Parasitol. 138,
83–87) based on epitope-specific monoclonal antibodies
suggesting that this region undergoes a conformational
change upon infection.
The biotinylation of proteins is a commonly used tool for the
affinity purification of proteins (1). It takes advantage of the
highly specific interaction between biotin and avidin or its bac-
terial homolog, streptavidin. Protein biotinylation utilizes bio-
tin derivatives containing an active ester group that reacts with
primary amines of proteins, particularly with the N terminus
and the -amino group of lysine residues. A novel amide bond is
thereby formed, and the biotin moiety is covalently attached to
the respective amino group, often separated by a spacer of
defined size. The biotin derivative sulfosuccinimidyl-6-(bioti-
namido) hexanoate (sulfo-NHS-LC-biotin)3 is a hydrophilic
reagent that is excluded from most cells and is therefore used
for the biotinylation and subsequent affinity purification of cell-
surface proteins.
Recently, we used sulfo-NHS-LC-biotin to label proteins
exposed on the surface of human red blood cells infected with
themalaria parasitePlasmodium falciparum (iRBC) (2). In con-
trast to the non-infected erythrocyte (RBC), the plasma mem-
brane of the infected erythrocyte was permeable for this biotin
derivative (2). Uptake of the compound occurs through the so-
called novel permeability pathways, which are parasite-induced
and have a broad specificity with a preference for anions (3–6).
Biotinylation of internal proteins can be minimized if the reac-
tion occurs in the presence of novel permeability pathway
inhibitors such as furosemide. The proteins that constitute the
novel permeability pathway are still unknown. The band 3
anion exchangerAE1 is themost abundant anion transporter in
RBC (7). The reactivity of an epitope-specific monoclonal anti-
body with band 3, which differs between infected and non-
infected erythrocytes, has been interpreted as a conformational
change in the protein in at least one of the extracellular domains
(8). Although band 3 itself does not appear to be the actual
channel protein mediating the novel permeability pathway (5),
its conformational change as a consequence of the infection
may nevertheless play an important role in the survival of the
parasite within its host cell. Therefore, we sought an experi-
mental strategy tomore precisely define the position within the
band 3 molecule where this conformational change could pos-
sibly occur.
In a recent proteome analysis, we used in situ biotinylation of
permeabilized iRBC to specifically label soluble parasite pro-
teins contained in the parasitophorous vacuole (9). Peptide
mass fingerprinting of 27 different biotinylated proteins
revealed a high reproducibility of the biotinylation patterns of
individual proteins in different experiments. These observa-
tions prompted us to investigate whether changes in protein
conformation are reflected by changes in biotinylation patterns
and whether this mapping can be exploited as an experimental
strategy to detect conformational changes in cell-surface pro-
teins. Although amino acid residue modifications by specific
tags and cross-linkers in combination with mass spectrometry
* This work was supported in part by Deutsche Forschungsgemeinschaft
Grant SFB 593 (to K. L.). The costs of publication of this article were
defrayed in part by the payment of page charges. This article must there-
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have been used as tools for probing the tertiary structure of
proteins (10–12), the use of biotin derivatives has additional
advantages: (i) labeled proteins can be readily visualized before
analysis; (ii) labeled peptides can be affinity-enriched; and (iii)
several membrane-impermeant derivatives exist, allowing the
selective labeling of cell-surface proteins. As a case study, we
have used bovine serum albumin (BSA) as a soluble model pro-
tein to show that specific, experimentally induced, conforma-
tional changes result in a highly reproducible biotinylation pat-
tern of lysine residues. Using this method, a comparison of the
biotinylation patterns of band 3 allowed us to identify a distinct
difference between iRBC and RBC.
EXPERIMENTAL PROCEDURES
Biotinylation of BSA and Carbonic Anhydrase—Fatty acid-
free BSA (Roth, Karlsruhe, Germany) was dissolved in phos-
phate-buffered saline (PBS) to a final concentration of 10
mg/ml. For analysis of the biotinylation pattern of BSA, 1 ml of
the solution (containing 1.4  104 mol of BSA) was biotiny-
lated with 1-, 10-, 20-, 40-, and 60-fold molar eq (taking into
account 60 lysine residues/BSA molecule) of sulfo-NHS-LC-
biotin (Pierce) at 4 °C for 30 min. The reaction was stopped by
the addition of glycine to a final concentration of 100 mM. The
unreacted biotin derivative was removed from the sample by
centrifugation at 3000 g using aMilliporemicroconcentrator
with a size exclusion of 5 kDa. This stepwas repeated twice after
dilution with PBS before determining the protein concentra-
tion using the BCA assay (Pierce). For bovine carbonic anhy-
drase, 1.2  104 mol of carbonic anhydrase were biotinylated
using a 40-fold molar excess of biotin derivative and processed
as described for BSA. For analysis of the artificially induced
conformational changes, BSA and carbonic anhydrase were
dissolved in PBS as described above and subjected to an ele-
vated temperature of either 56 or 80 °C for 30 min before cool-
ing to room temperature and biotinylationwith a 40-foldmolar
excess of biotin derivative. For affinity purification of the bio-
tinylated proteins, 72 l of streptavidin-Sepharose beads
(Pierce) were washed extensively with PBS containing 1% (v/v)
Nonidet P-40 beforemixing the beadswith 100g (1.44 106
mol) of biotinylated proteins. After overnight incubation at
4 °C, the unbound non-biotinylated protein fraction was
obtained as a supernatant after centrifugation at 10,000  g for
10 min. The beads containing bound biotinylated protein
were washed consecutively in 10 mM Tris-HCl (pH 7.5), 0.2%
Nonidet P-40, 2 mM EDTA, and 150 mM NaCl; in 10 mM
Tris-HCl (pH 7.5), 0.2% Nonidet P-40, 2 mM EDTA, and 500
mMNaCl; and finally in 10 mM Tris-HCl (pH 7.5). The bound
protein fraction was eluted from the beads by boiling in 500
l of denaturing SDS-PAGE sample buffer and separated by
12% SDS-PAGE.
Biotinylation of Erythrocyte Membrane Proteins—RBC were
obtained from blood group A donors and infected with the
human malaria parasite P. falciparum using standard condi-
tions. RBC and iRBC were cultured separately in RPMI 1640
medium in the presence of 10% human plasma under standard
conditions (13). Erythrocytes infected with mature stage para-
sites were isolated from culture by plasmagel flotation, result-
ing in 90% iRBC (14). Biotinylation of intact erythrocytes
(either infected or non-infected) was performed as described
(4). Briefly, 2  108 RBC or iRBC were washed with PBS (pH
7.6), incubated in the same buffer containing different concen-
trations of the biotin derivative (2, 1, and 0.5 mg/ml) for 1 h at
4 °C in the presence of 100 M furosemide, and subsequently
sedimented at 1300  g for 5 min at 4 °C. To block and remove
unreacted biotin derivative molecules, cells were washed three
times with PBS (pH 7.6) containing 100 mM glycine and then
with PBS. To enrich for membrane proteins, cells were resus-
pended in distilled water supplemented with a protease inhib-
itor mixture containing antipain, chymostatin, aprotinin, tryp-
sin inhibitor, Na-EDTA, pepstatin, leupeptin, and elastatinal
(each at a concentration of 1g/ml) and lysed by three cycles of
freezing and thawing. The membrane fraction was sedimented
by centrifugation at 18,000  g for 20 min, solubilized in SDS-
PAGE sample buffer, and separated by 7.5% SDS-PAGE.
Western Blot Analysis—Proteins separated by SDS-PAGE
were transferred to nitrocellulose membranes using standard
procedures. To detect biotin-labeled proteins, the membranes
were blocked with 3% BSA in PBS (pH 7.4) for 1 h at room
temperature before incubation for 20 min with alkaline phos-
phatase-conjugated streptavidin (1:10,000/3% BSA in PBS (pH
7.4); Pharmingen). The membranes were washed three times
with 10 mM Tris-HCl (pH 7.4) and 150 mM NaCl, and the bio-
tin-labeled proteins were visualized after staining with nitro
blue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate.
Sample Preparation for Mass Spectrometry (MS)—Protein
bands were excised from polyacrylamide gels and subjected to
in-gel trypsin digestion before MS analysis (15). Briefly, the
excised spots were washed with 50% (v/v) acetonitrile in 200
mM ammonium bicarbonate, and the destained protein was in
gel-reduced with 10 mM dithiothreitol in 100 mM ammonium
bicarbonate for 1 h at 56 °C and alkylated with 50 mM iodoac-
etamide in the same buffer for 45 min at room temperature in
darkness. The gel pieces were washed with 100mM ammonium
bicarbonate, dehydrated in acetonitrile, and dried. The gels
were re-swollen in 15l of 40mM ammoniumbicarbonate con-
taining 20g/ml sequencing-grade trypsin (PromegaCorp.) for
45 min at 4 °C. Excess protease-containing solution was dis-
carded, and 5l of 5mMammoniumbicarbonatewere added to
keep the gel pieceswet during the 18-h proteolytic cleavage step
at 37 °C. To extract the peptides, 15 l of diffusion solution
(10% acetonitrile and 1% trifluoroacetic acid) were added, and
the samples were sonicated for 45 min at 37 °C. The soluble
portion of the sample was evaporated to dryness. ForMSmeas-
urements, the samples were redissolved in 15 l of 0.1% (v/v)
trifluoroacetic acid and 5% (v/v) acetonitrile in water. The pep-
tides were purified and concentrated using ZipTipTM columns
made from the reverse chromatography resins POROS R2 and
Oligo R3 (Applied Biosystems). The bound peptides were
washed with a solution of 0.5% formic acid and eluted from the
ZipTipTM columns with 2 l of 33% (v/v) acetonitrile and 0.1%
trifluoroacetic acid saturated with -cyano-4-hydroxycin-
namic acid directly onto amatrix-assisted laser desorption ion-
ization (MALDI) sample plate and air-dried before analysis in
the mass spectrometer.
Alternatively, for affinity enrichment of biotinylated tryptic
peptides, SDS-PAGE-separated proteins were transferred to
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nitrocellulose membranes and visualized by Ponceau staining.
The stainedmembranes were cut into 2 2-mm square pieces,
thoroughly destained with water, treated with 10 mM dithio-
threitol in 100mM ammonium bicarbonate for 1 h at 56 °C, and
alkylated with 50 mM iodoacetamide in the same buffer for 45
min at room temperature in darkness. The nitrocellulose pieces
were washed with 100 mM ammonium bicarbonate and dried.
Themembranes were incubated in aminimal volume of 40mM
ammonium bicarbonate containing 20 g/ml sequencing-
grade trypsin and incubated at 37 °C for 18 h. The tryptic pep-
tides were extracted from the membrane pieces twice using
20% acetonitrile in 1% trifluoroacetic acid, with sonication at
37 °C for 45 min. The eluted peptides were resuspended in 500
l of 100mM ammonium bicarbonate and incubated overnight
with 72 l of washed streptavidin-Sepharose beads to affinity
purify the biotinylated peptides. The unbound non-biotiny-
lated peptide fraction was obtained as a supernatant after cen-
trifugation at 10,000  g for 10 min. This fraction was evapo-
rated to dryness and resuspended in 0.1% trifluoroacetic acid
before processing for MS. The Sepharose beads containing
bound biotinylated peptides were washed three times with 100
mMammoniumbicarbonate and 1%octyl glucoside. The bound
peptides were eluted with 70% acetonitrile, 5% trifluoroacetic
acid, and 1 mM D-biotin in 100 mM ammonium bicarbonate at
room temperature for 2 h. The solution was evaporated to dry-
ness and resuspended in 0.1% trifluoroacetic acid before proc-
essing for MS.
MS Analysis—MS was performed using a Bruker Daltonics
UltraflexTM mass spectrometer equipped with a nitrogen laser
(337 nm laser, 3-ns pulse width, and 50-Hz repetition rate) and
panoramic mass range focusing (PANTM) technology and high
precision calibration (HPCTM) for high mass accuracy. For
analysis of intact protein, mass spectra were acquired after an
external calibration using the reference protein standards tryp-
sinogen, protein A, bovine albumin, protein A2 , and bovine
albumin2 (protein calibration standard II, Bruker Daltonics).
Mass spectra were acquired in the linear positive mode with a
pulsed extraction using 100 laser shots, and the masses were
assigned and processed using BioToolsTM and flexAnalysisTM
software (Bruker Daltonics). For the trypsin digests, peptide
mass fingerprint spectra were acquired in the reflectron posi-
tivemode with a pulsed extraction using an average of 100 laser
shots. The spectra were acquired after an external calibration
using reference peptides (peptidemixture II, BrukerDaltonics).
The spectra were further internally calibrated using trypsin
autolysis peaks (842.5100 and 2211.1046 Da). Monoisotopic
masses were assigned and processed using BioToolsTM and
flexAnalysisTM software before submission to the Mascot pro-
gram (www.matrixscience.com) for searches against the non-
redundant NCBI Database. The following variable modifica-
tions were used in the searches: methionine oxidation, lysine
sulfo-NHS-LC-biotin-labeled, pyroglutamic acid from Glu at
the N terminus, pyroglutamic acid from Gln, and a fixed cys-
teine carbamidomethylation modification. To analyze the
effect of missed proteolytic cleavage of peptides on the identi-
fication of the proteins and biotinylated lysine residues, the
searcheswere done allowing complete cleavage (0missed cleav-
age sites) and allowing one or twomissed cleavage sites. Amass
accuracy of 50 ppm or better was used in all identifications.
Tandem mass spectrometry (MS/MS) analysis was done
using the LIFTTMmode to provide i, a, b, and y ions. Themasses
of the fragmented ions were submitted to the Mascot program
for data base searching using the following parameters: peptide
mass tolerance of 100 ppm,MS/MS tolerance of 0.7Da, and two
missed cleavage sites. The variable and fixed modifications of
amino acid residueswere used as described for the peptidemass
fingerprint analyses.
To analyze the spatial distribution of lysine residues across
the structures of BSA and carbonic anhydrase II, the crystal
structure of the latter enzyme (Protein Data Bank code 1V9E)
was examined. As no crystal structure of BSA has been depos-
ited in the Protein Data Bank, a homology model was obtained
from the SWISS-MODEL Repository (17) based on the crystal
structure of human serum albumin as a template (Protein Data
Bank code 1N5U). To detect possible correlations between the
degree of biotinylation, the local environment of lysine resi-
dues, and the solvent-accessible surface (18), their involvement
in hydrogen bonding, the hydrogen bond energy, and the local
electrostatic potential were studied. The latter was computed
and visualized using the MOLCAD module of SYBYL 7.1 (19);
hydrogen bond energies were calculated using the MAB force
field implemented in MOLOC (20).
RESULTS AND DISCUSSION
Biotinylation of BSA Is Saturable but Incomplete—Sulfo-
NHS-LC-biotin derivatives possess an active ester group that
reacts with the primary amines of proteins and/or the -amino
group of lysine residues, thereby forming an amide bond (Fig.
1). For each lysine residue, this reaction results in an increase in
mass of 339.161Da. If all 60 lysine residues of the BSAmolecule
were biotinylated, the calculatedmass shift of the proteinwould
FIGURE 1. The sulfo-NHS-LC-biotin derivative reacts with primary amines
to form a stable amide bond. The primary amine may be the N-terminal
amino group or the -amino group of lysine residues. The figure was modified
from that supplied by Pierce.
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be 20.34 kDa. BSAwas biotinylatedwith increasingmolar ratios
of sulfo-NHS-LC-biotin to protein and analyzed by time-of-
flight MS in linear mode. The mass of the protein increased in
an almost linear correlation with the molar excess of the biotin
derivative, up to a 40-fold molar excess of the derivative (Table
1). The maximal increase we observed was 6.1 kDa, accounting
for 18 biotinylated lysine residues. Thus, the biotinylation of
lysine residues in the BSA molecule is incomplete. Analysis of
the biotinylated protein by SDS-PAGE confirmed the increase
in molecular mass of Coomassie Blue-stained protein, which
was verified by biotin detection with streptavidin (supplemen-
tal Fig. 1).
To investigate whether biotinylation occurs randomly or
whether specific lysine residues are preferentially labeled, biotiny-
lated BSA was analyzed by peptide mass fingerprinting. Trypsin,
themost commonly used protease to generate peptides for pep-
tidemass fingerprinting, cleaves peptides at theC termini of the
basic amino acid residues arginine and lysine. Because biotiny-
lation occurs at the protonated -amino group of the lysine
residue, the modification is likely to affect tryptic cleavage,
leading to the generation of peptides containing amissed cleav-
age site. To analyze biotinylated peptides, BSA was first trans-
ferred to nitrocellulose filters and trypsinized. Subsequently,
the peptides were affinity-purified and subjected to MS using
the reflectron mode. Data base searches assuming complete
cleavage were unable to identify BSA-derived peptides, indicat-
ing that the peptides contained cleavage sites that were not
recognized by the protease. Allowing for one or two missed
cleavage sites led to an increased number of identifiable pep-
tides, with only one additional peptide having twomissed cleav-
age sites (supplemental Fig. 2). In the subsequent bioinformat-
ics analyses, we therefore allowed for twomissed cleavage sites.
BSA biotinylated with different molar ratios of sulfo-NHS-LC-
biotin was excised from polyacrylamide gels, cleaved with tryp-
sin, and subjected to MS in the reflectron mode. Together, the
peptides identified contained 34 of the total 60 lysine residues
and covered 56% of the BSA sequence. This coverage was the
same as obtained for non-biotinylated BSA (data not shown).
With increasing concentrations of the biotin derivative in the
biotinylation reaction, the numbers of biotinylated peptides
increased. Each of these peptides was then analyzed byMS/MS,
allowing the identification of individual biotinylated lysine res-
idues. The samples treated with higher concentrations of the
biotin derivative contained more biotinylated residues. As in
the analysis of the intact protein, the correlation between the
numbers of biotinylated lysines and biotin concentration was
almost linear (Table 2). The numbers of the modified lysine
residues identified by MS/MS correlated with the predicted
numbers after MS of the intact protein in the linear mode
(Table 1). More important, when biotin concentrations below
the point ofmaximal incorporationwere used, labeling of lysine
residues did not occur randomly, but at specific sites. Residues
that were biotinylated with lower concentrations of the deriva-
tive were also labeled when higher concentrations were used.
These observations indicate a concentration-dependent, pref-
erential accessibility of individual residues.
Recently, Huang et al. (21) used hydrophilic and hydropho-
bic cross-linkers and subsequentMS to probe the tertiary struc-
ture of BSA.One of the cross-linkerswas bis(sulfosuccinimidyl)
suberate, which has a reaction mechanism similar to that of
sulfo-NHS-LC-biotin. They identified a total of 20 modified
lysine residues, 13 of which were also labeled with sulfo-NHS-
LC-biotin in our experiments. Three of the modified residues
(Lys138, Lys140, and Lys495) identified in the previous studywere
detected in all of our experiments, although they were non-bio-
tinylated. One residue (Lys88) was not detected at all in our
experiments, and one residue (Lys399)was detected only once in
its biotinylated form. Two residues (Lys437 and Lys523) were
also biotinylated in our study, but only after exposure of BSA to
high temperature (see below).We also identified five additional
lysine residues (Lys36, Lys100, Lys266, Lys498, and Lys559) that
had not been detected by Huang et al. (21), and it is therefore
not possible to directly compare the labeling status in the two
experiments. In conclusion, different ionization conditions
(electrospray versus MALDI) revealed almost identical pep-
tides, and despite the use of different modifying reagents
(bis(sulfosuccinimidyl) suberate versus sulfo-NHS-LC-biotin),
the majority of the modified residues were identical in both
TABLE 1
Effect of an increase in the molar ratio of sulfo-NHS-LC-biotin to BSA
on the mass of BSA
BSA was biotinylated with increasing molar ratios of sulfo-NHS-LC-biotin to pro-















aEach modified lysine residue resulted in an increase in mass of 339 Da.
TABLE 2
Biotinylation of individual lysine residues follows a
concentration-dependent specific order
BSA was biotinylated with sulfo-NHS-LC-biotin at a molar excess of 1-, 10-, 20-,
40-, and 60-fold. Tryptic peptides were analyzed byMS/MS to identify biotinylated





 1 10 20 40 60
Lys36   
Lys100   
Lys156   
Lys160    
Lys204   
Lys211    
Lys228   
Lys235     
Lys245   
Lys266  
Lys374   
Lys401    
Lys412  
Lys420  
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studies, underscoring the reproducibility of the biotinylation
reaction described above.
In light of a recent report (22) that lysine modification by
N-succinimidyl propionate lacking the biotin moiety may
induce conformational changes in a low molecular mass pro-
tein that is detectable byCDmeasurements, we investigated the
possibility that the reaction between sulfo-NHS-LC-biotin and
the lysine residues induces structural changes in the BSA mol-
ecule. CD spectroscopy was used to monitor changes in the
structures of untreated BSA and BSA reacted with increasing
molar ratios of the biotin derivative as described above. Far-UV
(180–300 nm)measurementswere performed at room temper-
ature with a Jasco 810 spectrometer using 50 mM BSA in
HEPES. The observed protein CD spectrum is an average of CD
signals from all structures and
reflects the geometric variability in
the secondary structure. There was
no significant difference in the spec-
tra of untreated BSA and BSA
reacted with the biotin derivative at
different molar ratios (data not
shown). In all the cases, the BSA
structure is predominantly com-
posed of -helices, and the biotiny-
lation reaction did not induce struc-
tural changes that were detectable
by CD. In comparison with the pro-
tein of the light-harvesting complex
that has been analyzed in a previous
study (22) and that has a maximum
of two disulfide bonds, the BSA
molecule forms 17 intramolecular
disulfide bonds (23). We anticipate
that the structural compactness of
BSA is the reason why this protein
does not undergo a conformational
change upon biotinylation.
To obtain some structural insight
into the accessibility of the lysine
residues of BSA, a homology model
of BSA (NCBI accession number
P02769) based on the crystal struc-
ture of human serum albumin as a
template was consulted (sequence
identity of 76%). All lysine residues
of BSA were examined with respect
to a possible correlation with the
following structural descriptors: (i)
spatial accessibility (visual inspec-
tion and calculation of the solvent-
accessible surface), (ii) involvement
in a hydrogen bond along with the
associated energy of these hydrogen
bonds, and (iii) electrostatic poten-
tial in the close environment of the
considered residues. For descriptors
i and iii, no clearly evident correla-
tion could be discovered, whereas
the involvement of a lysine residue in a hydrogen bond seems to
significantly decrease the probability of biotinylation (supple-
mental Table 1). For BSA, only 7 of 24 lysine residues involved
in a hydrogen bond reacted with sulfo-NHS-LC-biotin. How-
ever, it has to be taken into account that two of these seven
lysines that do not fit the correlation aremutated in the homol-
ogy model with respect to the crystallographically character-
ized template, thus increasing the uncertainty about their
actual involvement in hydrogen bonds. To seek additional
descriptors that might explain the deviating reactivity of the
lysine residues involved in hydrogen bonding, we calculated the
average energy of the hydrogen bonds separately for those
lysines that become biotinylated and those that remain non-
biotinylated. The mean energy for the non-biotinylated resi-
FIGURE 2. Sections of the MALDI mass spectra for BSA biotinylated with sulfo-NHS-LC-biotin after expo-
sure to an elevated temperature of 80 °C compared with BSA biotinylated at room temperature (RT). In
A, the peak at m/z 1979.113 corresponds to peptide 437– 451 of BSA with sequence KVPQVSTPTLVEVSR, in
which Lys437 is biotinylated. The arrow indicates the monoisotopic peak cluster corresponding to the biotiny-
lated peptide. Lys437 is biotinylated only after BSA is exposed to 80 °C. In B, the peak at m/z 2810.100 corre-
sponds to peptide 508 –528 of BSA with sequence RPCFSALTPDETYVPKAFDEK, in which Lys523 is biotinylated.
The arrow indicates the monoisotopic peak cluster corresponding to the biotinylated peptide. Lys523 is biotin-
ylated only after BSA is exposed to 80 °C. Intens., intensity; a.u., arbitrary units.
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dues is more favorable by a factor of 3 than that for those that
become biotinylated (excluding Lys100 and Lys245, which are
mutated in themodel with respect to the template). This rather
pronounced discrimination based on the residue geometries
found in the experimental structures suggests that those of the
originally hydrogen-bonded lysines that are biotinylated have
been involved in significantly weaker hydrogen bonds. Obvi-
ously, the participation in sufficiently strong hydrogen bonds
prevents reaction with sulfo-NHS-LC-biotin, which is in
accordance with previous notions that the involvement in
hydrogen bonding may reduce the reactivity of lysine residues
(22, 24).
Elevated Temperatures Expose Novel Lysine Residues—The
highly reproducible biotinylation pattern of BSA and the obvi-
ously highly ordered accessibility of individual lysine residues
prompted us to investigate whether treatments that result in
conformational changes in the protein affect biotinylation pat-
terns. BSA has a heart-shaped structure of three homologous
domains that are divided into nine loops by 17 disulfide bonds
(23). Heat-treated serum albumin undergoes a conformational
change that is reversible as long as the temperature does not
exceed 65 °C. The conformational change induced by higher
temperatures is irreversible, but does not necessarily result in
the complete destruction of the ordered structure (25). In our
experiments, BSA was biotinylated at room temperature and
after heating at 56 or 80 °C. For BSA treated at 56 °C, MS anal-
ysis revealed the identical biotinylated peptides as detected at
room temperature. At 80 °C, two additional lysine residues
(Lys437 and Lys523) were found biotinylated byMS/MS. As both
of these residueswere identified as non-biotinylated in the sam-
ples treated at the lower temperatures (Fig. 2, A and B), we
conclude that heating, leading to an irreversible conforma-
tional change in the protein, allows access of biotin to these
residues. Lys523 is in helix 2 of subdomain IIIb of BSA (23), and
we suggest that this domain undergoes a considerable and irre-
versible conformational change upon heating to 80 °C. It is
noteworthy that both Lys437 and Lys523 were identified as
labeled residues in the study by Huang et al. (21), who per-
formed the reaction at room temperature. Although the molecu-
lar masses of sulfo-NHS-LC-biotin and bis(sulfosuccinimidyl)
FIGURE 3. Biotinylation pattern of the highly flexible domain of the band 3 molecule (modified from Zhu et al. (29)). The underlined lysine residues Lys814
and Lys817 were detected in both infected and non-infected erythrocytes and were not biotinylated. Lys851 was detected only in RBC and was not biotinylated.
Lys829 and Lys892 were detected in both RBC and iRBC and were biotinylated. Lys826 was detected in both RBC and iRBC but was biotinylated only in RBC,
indicating that, in iRBC, this residue is not accessible to the external media. *, biotinylated lysine residue in RBC; #, biotinylated lysine residue in iRBC. TMDs,
transmembrane domains.
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FIGURE 4. Differential biotinylation of lysine residues of band 3 in iRBC and RBC. Shown are enlarged sections of the MALDI mass spectra for band 3 from
P. falciparum-infected erythrocytes and non-infected erythrocytes. In non-infected erythrocytes (RBC), Lys826, Lys829, and Lys892 in peptides with masses
1612.76, 1027.700, and 2864.19 Da, respectively, were biotinylated. In infected erythrocytes, Lys829 and Lys892 were biotinylated, but Lys826 was not. The arrow
in A shows the absence of the biotinylated peptide in the spectra for band 3 from infected erythrocytes. a.u., arbitrary units. Intens., intensity.
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suberate are similar (556 and 572 Da, respectively), the lengths of
the spacer arms differ by2-fold, whichmay explain the differen-
tial accessibility of these residues to the two compounds.
We also carried out a similar analysis on carbonic anhydrase,
a 28-kDa single-domain proteinwith a dominating-sheet that
extends throughout the entire molecule (26). The thermal
denaturation curve of carbonic anhydrase has a classical sig-
moid shape with a melting temperature at 64.2 °C (27). Only
minor structural changes, if any, are to be expected at this pre-
transition temperature (27). Carbonic anhydrase has a total of
18 lysine residues. After biotinylation with a 40-fold molar
excess of the biotin derivative at either room temperature or
56 °C, 15 lysine residues were detectable byMS, seven of which
were biotinylated (supplemental Table 2). Heating the protein
to 80 °C and cooling to room temperature prior to biotinylation
had no effect on this pattern because of the rapid refolding of
the protein.
Also in the case of bovine carbonic anhydrase II, we exam-
ined the available crystal structure for the putative accessibility
of the lysine residues. The same descriptors as described above
were studied. Similarly, analysis suggested a correlation
between the involvement in hydrogen bonding and the
decreased probability of biotinylation (supplemental Table 3).
Only one of eight lysine residues involved in a hydrogen bond is
biotinylated.
As shown for BSA, heating the protein increased the number of
biotinylatable lysine residueswithout the loss of biotinylation sites
accessible at low temperature. Presumably, the higher tempera-
ture resulted in a generally more open, possibly partially unfolded
or denatured structure of the BSAmolecule. This observation is
supported by our CD spectrometry measurements showing a
change in the conformation of BSAwith a shift from a predom-
inantly -helix structure to the more open -sheet conforma-
tion after exposure to an elevated temperature of 80 °C. How-
ever, we anticipate that conformational changes, others than
those induced by elevated temperature, do not necessarily
result in a gain of biotinylatable sites. Depending on the exper-
imental circumstances, a loss of such sites, e.g. as a result of
steric hindrance, is equally possible.
Comparison of the Biotinylation Patterns of Band 3 in RBC
and iRBC—Biotinylation of BSA revealed a linear correlation
between the molar ratio of the biotin derivative and biotiny-
lated lysine residues until all sufficiently reactive residues were
saturated. The band 3 protein is present on the erythrocyte
surface at 106 copies/cell (28). To ensure excess of the biotin
derivative, standardized numbers of either infected or non-in-
fected cells were biotinylated using concentrations of sulfo-
NHS-LC-biotin ranging from 0.5 to 2 mg/ml. The reactions
were carried out in the presence of furosemide to minimize
internal labeling of infected erythrocytes (4). Proteins con-
tained inmembrane fractions of erythrocyteswere separated by
SDS-PAGE and stained with Coomassie Blue, and the band
corresponding to band 3 was excised and analyzed. As
described above, in the data base searches, twomissed cleavage
sites per peptide were allowed. Within the chosen range, the
concentration of the biotin derivative did not have an effect on
the biotinylation status of individual lysine residues (data not
shown).
Band 3 is a multimembrane-spanning protein with 11–14
transmembrane domains (16, 29). According to the predicted
topology, five domains are exposed extracellularly. Whereas
three domains are composed of fewer than 10 amino acid resi-
dues, two domains (Phe543–Pro568 and Glu626–Met663) are
composed of 26 and 38 amino acids, respectively. One addi-
tional domain (Gly802–Leu835) is predicted to exhibit enhanced
flexibility, which can vary between an extracellular and intra-
cellular topology. Although the various models differ in details,
they are consistent in that, of the total 29 lysine residues, nine
residues reside in the extracellular loops, four of which are
located in one of two large loops. Four additional lysine residues
are found in the flexible loop.
After surface biotinylation of RBC, three lysine residues were
found to be biotinylated (Fig. 3). Two of these residues (Lys826
and Lys829) are located in the prominent flexible loop, and one
(Lys892) in a predicted intracellular domain. In contrast, in
iRBC, only two lysine residues (Lys829 and Lys892) were biotin-
ylated. Although it is conceivable that conformational changes
take place only in a certain percentage of the band 3 molecules,
we were unable to detect biotinylated Lys826 in iRBC, and con-
versely, peptides from RBC containing Lys826 were always bio-
tinylated (Fig. 4, A–C). These results suggest that all band 3
molecules undergo a conformational change in iRBC. We
have no explanation why Lys892, which is predicted to be
intracellular, was found biotinylated in both samples. The
overall low sequence coverage for band 3 (30%) can be attrib-
uted to the high proportion of hydrophobic domains present
in this molecule.
In conclusion, biotinylation of proteins is highly reproduci-
ble and appears to be dependent on protein conformation. Pos-
sibly the involvement of the -amino group of lysine in hydro-
gen bonding provides an explanation for the gradual reactivity
observed for the various residues. Thus, conformational
changes or alternative structural transformations in proteins
lead to alternative biotinylation patterns. As shown for the band
3molecule in non-infected andmalaria parasite-infected eryth-
rocytes, this approach allowed us to identify a differentially bio-
tinylated lysine residue. This residue is positioned in the extra-
cellular flexible loop in a region that is also differentially
recognized in non-infected and infected erythrocytes by a
monoclonal antibody (8).We suggest that surface biotinylation
of intact cells followed by MS is a rapid method for identifying
putative conformational changes in surface proteins, for exam-
ple, following pathogen infection or under varying physiologi-
cal conditions.
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